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Abstract 
Shift work has been hypothesized to associate with increase the risk of metabolic syndrome 
(MetS). It is a complicated syndrome that demonstrated as a common precursor for 
developing cardiovascular diseases and/or type 2 diabetes mellitus. The study was 
conducted to estimate the prevalence of MetS among health personnel and to examine the 
effect of rotating shift work schedule on biomarkers of MetS and inflammation. A 
comparative analytical cross sectional study was conducted on a sample of 310 health 
care personnel, 100 current daytime workers compared with 210 rotating shift workers. A 
questionnaire on socio-demographic (sex, age, marital status, income, job, governorate), 
past medical history, health-related behaviors such as (smoking and physical activity) and 
occupational history about shift work, health examination including anthropometric and 
arterial blood pressure measurements, and laboratory investigations. We used the Adult 
Treatment Protocol III National cholesterol Education Programme of America (ATPIII) 
indicators for diagnosis and determination of MetS. The syndrome was met if an individual 
had three or more of the following criteria: waist circumference >102cm in men and 
>88cm in women, fasting plasma glucose ≥110mg/dl, blood pressure ≥130/85mmHg, 
serum triglycerides ≥150mg/dl and serum HDL cholesterol <40mg/dl in male and 
<50mg/dl in female. Statistical analysis was performed using SPSS version 20. The overall 
prevalence of MetS among healthcare workers was 8.4% (9.0% among current daytime 
workers and 8.1% among rotating shift workers) without significant difference between 
males and females, and shift category. The most frequently altered component among 
healthcare workers was elevated C- reactive protein (44.5%), followed by high  
triglyceride (35.5%), increased total cholesterol (24.8%), and elevated BMI>30 (20.6%). 
The main risk factors for MetS in both sexes among rotating shift workers in descending 
order were as follow: high Blood pressure (OR = 59.5; 95% CI, 16.4- 215.8),high fasting 
blood sugar (OR= 43.9; 95% CI, 12.9- 149.1),high triglyceride (OR = 42.3; 95% CI, 5.5- 
326.6), obesity (elevated body mass index >30)(OR = 11.8; 95% CI, 4- 34.6), and low 
level of high density lipoprotein cholesterol (HDL) (OR = 1.6; 95% CI, 0.3- 6.1). MetS was 
prevalent among health care personnel in Gaza Strip, with a steady increase in its 
prevalence through age and BMI. There was no direct relationship between shift category 
and the occurrence of MetS and inflammation, other factors as genetic factors, lifestyle 
factors , the job itself may have more effects on the occurrence than shift category. From 
the results we recommended a need for managing hypertensive disorders among current 
day time and rotating shift workers, and urged that the health conditions of hospital 
employees should not be overlooked. Also, the attention of ministry of health is needed 
together with the individual practice of health behaviors to manage the MetS to prevent 
possible cardiovascular disease among current daytime and rotating shift workers. 
Keywords: Metabolic syndrome, current daytime workers, rotating shift workers, 
inflammation, risk factors. 
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Chapter (1) 
Introduction 
1.1 Introduction 
Metabolic syndrome (MetS) is multifaceted syndrome that usually occurs in general 
population, mainly in adults over 50 years of age (Timer et al., 2000). This syndrome has 
been described as a ‗‗clustering‘‘ of multiple risk factors for cardiovascular disease (CVD) 
(Buckland et al., 2007; Yasein et al., 2010) such as hypertension (HTN), dyslipidemia 
[specifically high triglycerides (TG), low levels of high-density lipoprotein (HDL), and 
increased small dense low-density lipoprotein (LDL)], obesity (particularly central or 
abdominal obesity), insulin resistance, and impaired glucose tolerance (IGT) or diabetes 
mellitus (DM) (Michael et al., 2007; Erem et al., 2008; Longo-Mbenza et al., 2010). MetS 
was also known as syndrome X, cardio metabolic syndrome, insulin resistance syndrome, 
Reaven‘s syndrome, CHAOS (an abbreviation for coronary artery disease, hypertension, 
atherosclerosis, obesity, and stroke) (Kaplan, 1989; Schindler, 2007). Patients with MetS 
have a twofold increased risk of mortality from coronary heart disease (CHD) (Kathleen et 
al., 2007).  
The increased prevalence of MetS has been attributed to changes in lifestyle, particularly 
with regard to new eating patterns and sedentarism (Cai et al., 2012; Kesse-Guyot, 2013). 
However, modern life has also brought changes to the work environment. Working hours 
that occurred during the daytime were extended in the last decades for a large number of 
services and production areas (Straif et al., 2007). 
The vast majority function of the circadian system is the internal cycling of physiological 
and metabolic events (Murphy & Campbell, 1996). In fact, many physiological processes 
display day–night rhythms, in addition to lipid and carbohydrate metabolism and blood 
pressure (BP) are subject to daily variation. 
The circadian rhythm and environmental conditions may become asynchronous in rotating 
shift workers whose night activity is out of leading to desynchronization of the normal 
phase relationships between biological rhythms within the circadian system (Klerman, 
2005). 
Recent epidemiological studies have reported an association between inflammation and 
thrombogenesis as a cause for CVD in patients suffering from the MetS (Hansson, 2005).  
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In addition, several studies have shown a positive relationship between elevated leukocyte 
count and risk of CHD suggesting that leukocyte count is related with metabolic and 
hemodynamic diseases typical of the MetS ( Targher et al., 1996). 
1.2 Research problem 
Metabolic syndrome (MetS) is considered a worldwide epidemic problem (Alberti et al., 
2009). It is estimated that approximately one fourth of adults worldwide carry the 
syndrome (Grundy, 2008). Individuals with MetS are at increased risk of developing type 2 
diabetes mellitus (T2DM) and CVD (Blaha et al., 2008; Salas-Salvado et al., 2008). People 
with MetS have a fivefold greater risk to develop T2DM and are in higher risk of 
morbidity and mortality from CVD, for this a combination of each risk factors which 
compose MetS interact in a synergic manner to accelerate the development of 
atherosclerosis (Stern et al., 2004). In USA which is a developed country MetS is about 
20%-30% (Aguilar-Salinas et al., 2005), while in some Asian countries like India and Iran 
higher prevalence rate has been reported (Azizi et al., 2003; Deepa et al., 2007). 
In 1999, Knutsson and Boggild reviewed several studies and concluded that there is 
evidence of a strong association between shift work and CVD, with shift workers having 
on average 40% excess risk for ischemic heart disease as compared to day workers. 
Rotating shift work was found to be an independent risk factor for MetS in European men 
(OR, 1.51; 95% CI, 1.01-2.25) when corrected for age and physical-activity variables 
(Sookoian et al., 2007). The recent evidences indicate that MetS is highly prevalent in 
Gaza Strip population, with a steady increase in MetS prevalence through age and BMI. 
The overall prevalence of MetS in Gaza Strip cohort was 23.0% and 39.5% according to 
NCEP/ATP III and IDF definitions respectively (Sirdah et al., 2012). Another study done 
among clinic patients in Gaza showed that the prevalence of MetS was 59.5%, without 
difference between male and female, the main risk factors for MetS were high BP (78.8% 
for systolic and 73.8% for diastolic BP), large waist circumference (WC) (67.9%), high TG 
(78.6%), and high fasting blood sugar (FBS) (86.4%). HDL cholesterol was protective but 
not statistically significant (Jamee et al., 2013). 
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1.3 Justification 
A number of studies have shown that shift work is related with MetS, a study done by Ye 
et al., showed that prevalence of MetS for shift worker was 15.3%, and for daytime worker 
was 2.8% (Ye et al., 2013). Fujino et al. (2006) in their prospective study showed that the 
rotating-shift workers had a significantly higher risk of death due to ischemic heart disease 
(RR = 2.32, 95% CI: 1.37, 3.95; p = 0.002). Also, a cross sectional study done by Sookoian 
et al. (2007) demonstrated that the odds ratio for MetS in rotating shift workers compared 
with day workers was 1.51 (95% CI 1.01–2.25), but the evidence on a causal relationship 
is limited. 
In Gaza, most rotating shift workers at governmental hospitals complain from many health 
problems such as hypertension, obesity, diabetes, generalized fatigue, and decreased 
activities from the shift schedule they had.  
Because shift work hypothesized to increase the prevalence of MetS, and CVD and 
diabetes are an established public health issues, this is a field in need of further focus. 
According to our best knowledge and published literature there is no studies in Gaza 
investigated the prevalence of MetS and its biomarkers among healthcare workers and the 
potential effect of rotating shift work on MetS and inflammation biomarkers. 
The study will provide policy makers with evidence that could help them to organize shift 
working shifts in a more effective way and will provide evidence that could provide policy 
makers with evidence that could help in improving working conditions for employee who 
work in the Gaza Strip. Additionally the study will provide MOH with information that 
could be used to reform the working schedules in order to decrease the likelihood of 
developing NCDS due to working conditions . 
In this thesis, the main aim was to find out the prevalence of MetS among rotating  shift 
workers and to explore the association between shift work and MetS with further 
emphasizes on inflammation markers.  
1.4 General objective 
To find out the prevalence of MetS among rotating shift workers and to explore the effect 
of rotating shift work schedule on biomarkers of MetS and inflammation among 
Palestinian medical staff working in Gaza-governorate hospitals. 
4 
 
1.5 Specific objectives 
1. To determine the prevalence of metabolic syndrome (MetS) among rotating shift 
workers at Gaza governorate hospitals. 
2. To determine the prevalence of metabolic syndrome (MetS) among day workers at 
Gaza governorate hospitals. 
3. To explore if there is difference in prevalence of metabolic syndrome (MetS) in 
rotating shift workers with day workers. 
4. To explore any possible effect of rotating shift work schedule on inflammation 
markers as white blood cell count and C-reactive protein. 
5. To compare any possible change in inflammation markers between rotating shift 
workers and day worker. 
6. To explore the association between MetS and having abnormal inflammation 
markers. 
1.6 Research Questions 
1. What is the prevalence of  MetS among rotating shift workers at Gaza governorate 
hospitals? 
2. What is the prevalence of  MetS among current daytime workers at Gaza governorate 
hospitals? 
3. Is there difference in prevalence of metabolic syndrome (MetS) between rotating shift 
and day worker? 
4. Is there any effect of rotating shift work on acquisition of MetS? 
5. Is there any effect of rotating shift work on inflammation markers? 
6. Is there association between MetS and having abnormal inflammation markers? 
1.7 Study Context 
This study was conducted at the governmental hospitals of the Gaza Strip (GS). Services of 
hospitals are affected by many factors such as: political situation, demography and 
geography of the Gaza Strip, socioeconomic, and health services in the Gaza Strip. 
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1.7.1 Demography and Socio-economic Context: 
Palestine is situated on the eastern Mediterranean coast between the longitudes 34º 15' and 
35º 40' to the east of Grenache. And latitudes 29º 30'' and 33º 15' to the north of equator, 
and it has a long coast on the Mediterranean sea (224 Km). To the east it shares borders 
with Jordan and Syria, to the north with Lebanon, and to the south with Egypt (Saleh, 
1985). 
The total population of Palestine at mid-2015 was about 4.68 million; 2.38 million males 
and 2.30 million females. The estimated population of West Bank was 2.86 million of 
which 1.45 million males and 1.41 million females, while the estimated population of the 
Gaza Strip totaled 1.82 million of which 925 thousand males and 895 thousand females. 
The percentage of urban population at mid-2015 was 73.9%, while the percentages of 
population in rural and camps areas were 16.7% and 9.4% respectively. The percentage of 
individuals aged (0-14) constituted 39.4% of the total population at mid-2015 of which 
37.2% in the West Bank and 43.0% in the Gaza Strip. The elderly population aged (65 
years and over) constituted 2.9% of the total population of which 3.2% in the West Bank 
and 2.4% in the Gaza Strip at mid-2015 (PCBS, 2015). 
The unemployment rate for Palestine increased to 26.9% in Q2/2016 (25.8% in Q4/2015). 
The number of unemployed was 358,700 in the 2nd quarter 2016; distributed as 203,600 in 
Gaza Strip and 155,100 in the West Bank. The unemployment rate in Gaza Strip was 
41.7% compared with 18.3% in the West Bank in the 2nd quarter 2016. And the 
unemployment rate for males in Palestine was 22.1% compared with 44.7% for females in 
the 2nd quarter 2016. The highest unemployment rate in the 2nd quarter 2016 was 42.6% 
among youth aged 20-24 years. For years of schooling, the highest unemployment rate 
among females with 13 years of schooling and more was 50.9% . The highest 
unemployment rate among youth who have not completed any grade level reached 55%. 
The unemployment rate among youth graduates was 51% in the 1st quarter of 2016. The 
highest unemployment rate was 64% for graduates in education and teacher training, while 
the lowest unemployment rate of 25% was among law graduates (PCBS, 2016). 
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1.7.2 Political Context: 
The West Bank and the Gaza Strip have been under occupation by Israel since 1967. The 
Palestinian National Authority was established in 1994 following the Oslo agreement. 
However, there has been ongoing political turmoil and economic decline sparked, in 
particular, by the second intifada in September 2000 and in 2006, international community 
withdrew direct financial support for the Palestinian National Authority following the 
election of Hamas. In February 2007, a National Unity Government was formed but was 
not widely supported and was short- lived. Factional clashes continued and in Jun 2007 
Hamas took over control of the Gaza Strip. The ongoing Israeli blockade, imposed in June 
2007 after Hamas take- over control of the Gaza Strip. This action crippled the private 
sector, driving unprecedented numbers of Palestinian into unemployment and poverty. The 
situation in the Gaza Strip was further exacerbated as a result of the Israeli military actions 
during the years 2008, 2012 and 2014. By these wars vital infrastructure was damaged or 
destroyed, including manufacturing and commercial units, housing and other buildings, 
electricity, water and sanitation services. Access to health care for ordinary patients was 
severely restricted during the conflict and continued as a result of Israeli blockade (Saleh, 
2012). 
It can be concluded from all the above that any attempts to improve health status and solve 
health problems in this region will be less effective unless root causes of these problems 
would be addressed by ending the occupation, eliminating siege and rehabilitation of the 
economy. 
1.7.3 Health status context: 
The population in Palestine is in epidemiological transition, with the burden of 
noncommunicable diseases rising. In 2015, heart disease was the leading cause of death in 
Palestine, causing 27.5% of all reported deaths. Cancers, when combined together, were 
the second leading cause of death, accounting for 13.8 % of reported deaths, followed by 
cerebrovascular diseases (9.9%), perinatal period conditions (6.9%), diabetes mellitus 
(6.8%), respiratory system diseases (6.6%), and injuries (5.1%). This disease burden has 
contributed to the increase in costs in the health sector and necessitates a greater focus on 
health prevention and integrated disease management including mental health. In spite of 
the protracted crisis and – as noted by the Palestinian Ministry of Health − with the support 
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of the international community, achievements have been made in relation to some health 
indicators in recent years– although they compare negatively to health indicators in Israel. 
In 2015 the number of live births per 1,000 of population per year is still high compared 
with other countries. The reported crude birth rate was 28.8/ 1,000 of population, in West 
Bank was 26.7/ 1,000 and 31.8/ 1,000 was in the Gaza Strip. The crude death rate in 
Palestine was 2.9 per 1,000 of population; in Gaza Strip 2.7 per 1,000 of population, and in 
West Bank 3.0 per 1,000 of population and the infant mortality rate in Palestine was10.9 
per 1,000 of live births. Vaccination coverage is close to 100% (MOH, 2015).  
1.7.4 Health services in Palestine: 
The quality of the public health sector needs to be substantively improved. Most public 
health facilities are unable to provide safe and adequate services and need to be 
rehabilitated or upgraded. While Israeli authorities permit the access of medical supplies 
into Gaza, there are frequent breakdowns of medical equipment resulting from power 
interruptions and water impurities, among other factors. For this and other reasons, many 
patients are forced to seek treatment outside Gaza for a wide range of medical problems, 
which is difficult due to movement restrictions imposed by the blockade (UNRWA 
Operational Response, 2013). 
The Ministry of Health provides health services to Palestinians under its jurisdiction in 
accordance with the Palestinian Basic Law, which serves as the interim constitution, and 
the Public Health Law. The Ministry of Health has a network of 472 primary health care 
centers (418 in the West Bank and 54 in the Gaza Strip), and 26 hospitals (13 in the West 
Bank and 13 in the Gaza Strip) (MOH, 2015).  
The Ministry of Health is the main provider of secondary healthcare services (hospitals) in 
Palestine. It provides and oversees 3259 hospital beds which are distributed among 26 
hospitals in all governorates of the country. There are a total of 80 hospitals operating in 
Palestine with 5939 beds. These include 50 hospitals in the governorates of the West Bank, 
with 3502 beds (59% of the total). The remaining hospital beds are in the governorates of 
the Gaza Strip. A total of 809 beds at Ministry of Health hospitals are set aside for internal 
medicine and related disciplines, accounting for 24.8% of beds at Ministry of Health 
hospitals. These include 437 beds in the West Bank and 372 in the Gaza Strip. The 
Ministry of Health has also set aside 890 beds for general surgery and other surgery sub-
specializations, accounting for 27.3% of the beds provided at the Ministry of Health 
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hospitals. These include 444 beds in the West Bank and 446 beds in the Gaza Strip.  The Ministry 
of Health is the only institution in Palestine that makes beds available for the treatment of 
mental and psychological disorders. Two hospitals have such beds: one in the Gaza Strip, 
with 25 beds, and the other in the West Bank, with 180 beds (WHO, 2016). 
Nongovernmental organizations play an important role in service delivery, especially in 
providing tertiary, ambulatory and rehabilitative care services. In 2014, nongovernmental 
organizations operated 137 primary health care centers (129 in the West Bank and 8 in the 
Gaza Strip) and 34 hospitals (20 in the West Bank and 14 in the Gaza Strip), supplying 
about one-third of bed availability in Palestine. They are important providers especially for 
mental health counseling, physical therapy and rehabilitation. UNRWA provides services − 
mainly through fixed and mobile primary health care clinics as well as contracted hospitals 
− to registered refugees: to 727 471 people in the West Bank through 42 primary health 
centers and one hospital, and to 1 167 572 people in the Gaza Strip through 22 primary 
health centers. About 74% of eligible refugees utilized UNRWA‘s health services in 2014. 
(WHO, 2015).  
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1.8 Operational definitions 
Metabolic syndrome 
The metabolic syndrome is a cluster of risk factors for cardiovascular disease and diabetes 
that includes: abdominal obesity, glucose intolerance, hypertension and dyslipidemia 
(Anderson et al., 2001; Nesto, 2003; Carr et al., 2004; Yasein et al., 2010). 
Shift work 
In this study shift work defined as job schedule in which employees work hours than the 
standard hours of 7:30 am to 2:30 p.m. 
Circadian rhythms 
Any biological process that displays an endogenous, entrainable alternation of about 24 
hours. These 24-hour rhythms are driven by a circadian clock, and they have been widely 
observed in plants, animals, fungi, and cyanobacteria (Edgar et al., 2012). 
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2 Chapter (2) 
Literature Review 
In this chapter the researcher demonstrates the study's conceptual framework and describes 
the most common factors (independent factors) background characteristics of respondents, 
characteristics of facilities, then a comprehensive review of the study literature is presented 
regarding shift work and MetS that included HTN, dyslipidemia, obesity (particularly 
central or abdominal obesity), insulin resistance, and IGT.  
2.1 Conceptual Framework: 
Shift work can elevate the risk of MetS by various mechanisms. Physiological and 
biological mechanisms are essential, they are often related to activation of the autonomic 
nervous system, changed lipid, carbohydrate and other metabolic parameters. These factors 
may lead to increase risk for T2DM, CHD and inflammation. MetS disturbances have 
some joint cause that unphysiologic timing of physical activity in relation to circadian 
rhythms is a possible explanation for the negative impact on the cardiovascular system and 
T2DM. 
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Metabolic syndrome components                                        Inflammatory markers 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (‎2.1): Conceptual Framework: Effect of rotating shiftwork on biomarkers of 
metabolic syndrome and inflammation in Governmental hospitals in Gaza Strip 
As demonstrated in figure (2.1), the conceptual frame work for this study includes the 
following elements: 
2.1.1 Rotating shift work 
Shift work is associated with several health problems, possibly due to an impairment of 
biological rhythm specifically, MetS induces an almost twice increased risk for CHD 
(Aykan et al., 2013), a two to threefold increased risk for ischemic stroke (Yusuf et al., 
2004; Kurl et al., 2006) and an even greater risk for diabetes (Hanley et al., 2005). 
Rotating shift work 
 
 Dyslipidemia 
 Glucose intolerance 
 Hypertension 
 Abdominal obesity 
 
 CBC (Leukocyte count) 
 
 C- reactive protein 
(CRP) 
Diabetes mellitus 
Cardiovascular 
disease 
Inflammation 
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2.1.2 Metabolic syndrome components and inflammatory markers 
- Atherogenic dyslipidemia: This is characterized in routine lipoprotein by increased 
triglycerides and low concentrations of HDL cholesterol. Further detailed analysis often 
reveals other abnormalities, including small, dense LDL particles, small HDL particles, 
and increased levels of apolipoprotein B, all of which have independent atherogenic 
potential. 
- Glucose intolerance: The majority of patients with MetS exhibit evidence of insulin 
resistance, that characterized by glucose intolerance. Despite the strong association 
between insulin resistance, glucose intolerance, and other metabolic risk factors, 
mechanisms underlying the link to CHD risk factors are obvious. When glucose 
intolerance evolves into hyperglycemia that is sufficient to diagnose T2DM, this is 
considered to be a major independent CHD risk factor.  
- Hypertension: It is frequently associated with the several metabolic abnormalities, of 
which obesity, glucose intolerance, and dyslipidemia are the most common (Ferrannini & 
Natali, 1991). Studies demonstrated that both hyperglycemia and hyperinsulinemia activate 
the Renin angiotensin system (RAS) by increasing the expression of angiotensinogen, 
Angiotensin II, and the AT1 receptor, which, in concert, may contribute to the 
development of HTN in patients with insulin resistance (Malhotra et al., 2001). 
- Abdominal obesity: it is characterized clinically as increased WC; abdominal or visceral 
obesity and it is most strongly associated with MetS and considered as risk of CHD.  
-Elevated CRP and increased leukocyte count: The high levels of CRP and leukocyte 
count are associated with an increased WC (Soto González et al., 2006), insulin resistance 
(Deepa et al., 2006), BMI (Guldiken et al., 2007), and hyperglycemia and are increased 
with the number of the MetS components. It is more likely to be elevated in obese insulin-
resistant (McLaughlin et al., 2002). Furthermore, it has been demonstrated that CRP levels 
independently predicted the occurrence of future CVD (Ridker et al., 2003). 
2.1.3 Diabetes Mellitus and Cardiovascular diseases 
Cardiovascular disease is the main outcome of MetS (Isomaa et al., 2001; Mottillo et al., 
2010). However, T2DM is also a major outcome of MetS. Accordingly, there is vigorous 
evidence correlating shift work and T2DM derives from epidemiological studies which 
show that shift workers are at increased risk for getting T2DM (Kroenke et al., 2006; Pan 
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et al., 2011). In addition a various prospective and retrospective studies, reported that shift 
workers were found to have a 40% CVD risk increase (Bøggild & Knutsson, 1999). 
2.2 Metabolic syndrome (MetS) 
2.2.1 History of metabolic syndrome 
The provenance of metabolic syndrome (MetS) began in 1920 when Kylin, a Swedish 
physician, demonstrated the association of high BP, high blood glucose, and gout (Kylin, 
1923). Vague described in 1947, that the visceral obesity was related to metabolic 
abnormalities found in CVD and T2DM (Vague, 1947). Later, in 1965, Yalow and 
Berson developed insulin assay and correlated insulin levels and glucose lowering effects 
in resistant and non-resistant individuals. In 1988 lecture performed at the American 
Diabetes Association (ADA) meeting by Reaven coined the term Syndrome X and brought 
into focus the clustering of characteristics of MetS. Reaven now prefers the name, Insulin-
Resistance Syndrome feels insulin resistance is the common denominator for MetS. In 
1989, Kaplan renamed it ―The Deadly Quartet‖ and others then modeled the term "Insulin 
Resistance Syndrome" (Haffner et al., 1992). The first criteria for definition was made by a 
World Health Organization (WHO) diabetes group in 1998 (WHO, 1999). Followed by the 
European Group for the study of Insulin Resistance (EGIR) that modify WHO definition in 
1999 (Balkau & Charles, 1999). In 2001, the National Cholesterol Education Program 
Adult Treatment Panel (NCEP/ATP) submitted its definition (Cleeman, 2001), 
subsequently, in 2003 the American Association of Clinical Endocrinologists (AACE) 
offered its definition of the syndrome (Einhorn et al., 2003). After that in April 2005 the 
International Diabetes Federation (IDF) proposed a new definition of the MetS. 
2.2.2 General definition of the metabolic syndrome 
The metabolic syndrome is a cluster of risk factors for cardiovascular disease and diabetes 
mellitus that includes: abdominal obesity, glucose intolerance, hypertension and 
dyslipidaemia (Anderson et al., 2001; Nesto, 2003; Carr et al., 2004; Yasein et al., 2010). 
Cai et al. define the MetS as a group of metabolic abnormalities including elevated blood 
pressure, increased triglycerides, decreased high-density lipoprotein, abdominal obesity, 
and changes in blood glucose (Cai et al., 2012), which are associated with an elevated risk 
of developing T2DM and CVD as well as increased mortality (Wu et al., 2010). 
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2.2.3 Current definitions of the metabolic syndrome 
Just as there are many synonyms for MetS that have evolved over time, there are also 
several definitions of MetS started with the World Health Organization (WHO) was the first 
organization to publish the definition of MetS in 1998 (Alberti & Zimmet, 1998) and 
subsequently modified the definition in 1999 (WHO 1999). The WHO definition required 
three main criteria for the diagnosis of MetS. The compulsory criteria were the presence of 
impaired glucose regulation or diabetes and/or insulin resistance along with two of the four 
other risk factors: HTN, dyslipidemia, abdominal obesity, and microalbuminuria, as shown 
in table 2.1. 
The European Group for Study of Insulin Resistance (EGIR) published their definition in 
1999 (Balkau & Charles, 1999). The EGIR definition applies only to non-diabetics and the 
major criteria focused on the presence of hyperinsulinemia along with two of four other risk 
factors (hyperglycemia, HTN, dyslipidemia, central obesity), as shown in table 2.1. The 
National Cholesterol Education Program Adult Treatment Panel III (ATP III) published 
their criteria to diagnose MetS in 2001 (NCEP 2001). The presence of three of five risk 
factors: increased WC, low HDL cholesterol, high TG, high BP, and impaired fasting 
glucose (IFG), achieve the criteria for the diagnosis of MetS. 
American Association of Clinical Endocrinologists (AACE) put forth their definition in 
2003 and called it the "Insulin Resistance Syndrome" (Einhorn et al., 2003). The diagnosis 
depended on clinical judgment based on risk factors, irrespective of the number of risk 
factors present, and this definition was to be used only in non-diabetics. The American 
Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) made slight 
modifications to this definition in 2005, as shown in table 2.1 (Genuth et al., 2003; Grundy 
et al., 2005). The changes include TG, HDL, and HTN related therapies as equivalents of 
the metabolic factor‘s involvement and update in Insulin Fasting Glucose to>100 mg/dl. 
The most recent definition of MetS is from the International Diabetes Federation (IDF) in 
2005, as shown in table 2.1.  
Table 2.1 summarizes the criteria of the various definitions and highlights the differences. 
Different measures of obesity and insulin resistance are used by the various definitions. The 
most distinguished difference is that the EGIR and AACE definitions are limited to non-
diabetics, while the others include diabetics. The ATP III and EGIR have emphasized the 
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presence of visceral obesity as a major risk factor, while in the IDF definitions it is a 
required criterion, without which the diagnosis of MetS cannot be made. All the definitions 
agree on the following essence components of MetS: obesity, abnormal glucose levels, 
dyslipidemia, and HTN. 
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Table (‎2.1): Comparison of the different definitions for the Metabolic Syndrome (Alberti et al., 2005). 
IDF2005 
AHA/NHLBI200
5 
AACE2003 ATP III2001 EGIR1999 WHO1998 MetS Component 
Central obesity  and any 
of the following below: 
Central  obesity 
plus two of other 
four following: 
Depend up on 
clinical judgment 
irrespective of 
number of risk 
factors present: 
Three or more 
of the   
following five 
risk   factors: 
Hyperinsulinemia 
Plus two of the 
four following 
low insulin 
sensitivity  or   
IGF/IGT or Type 2 
DM  plus tow of 
other four 
following: 
MetS, Criteria for 
diagnosis 
WC Ethnic specific Men: waist 
circumference>1
02 cm 
BMI >25 kg/m2 Men: waist 
circumference
>102 cm 
Men: waist 
circumference >94 
cm 
Men: waist. hip 
ratio >0.90 in 
Obesity 
WC Ethnic specific Women: waist 
circumference 
>88 cm 
BMI >25 kg/m2 Women: waist 
circumference 
>  88 cm 
Women: waist 
circumference >80 
cm 
Women: waist. hip 
ratio> 0.85inand/or 
BMI > 30 kg/m2 
 
≥130/85 ≥130/85 ≥130/85 ≥130/85 ≥140/90 ≥140/90 Blood pressure 
(mmHg) 
IFG(Fast>100)mg/dl.  If 
FPG > 100 mg/dL, OGTT 
Glucose tolerance test is 
strongly recommended but 
is not necessary to define 
presence of the Syndrome. 
IFG(Fast>110) 
mg/dl 
IFG(Fast>110) 
mg/dl 
IFG(Fast>110) 
mg/dl 
IFG(Fast>110) 
mg/dl 
IFG(Fast>110) 
mg/dl 
plasma glucose 
mg\dl 
………….. ………….. IGT(2H >140) ……………… IGT(2H>140) IGT(2H>140)  
Type 2 DM Type 2 DM …………. Type 2 DM …………… Type 2 DM  
≥150 ≥150 ≥150 ≥150 ≥150 ≥150 Triglycerides(mg/dl) 
≤40 ≤ 40 ≤ 40 ≤ 40 ≤39 Men          ≤35 HDL (mg/dl) 
≤50 ≤50 ≤50 ≤50 ≤39 Women     ≤39  
Ethnic specific                                     
WC 
Update of ATP Other conditions 
Used only in non-
diabetics 
……………… Used only in non-
diabetics 
Microalbuminuria Other/ unique 
Features 
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2.3 Prevalence of metabolic syndrome 
The prevalence of the MetS is directly depend upon the definition used to describe the 
syndrome (Scott, 2003). Without a unifying definition, reports of prevalence have a varied 
in the USA and Europe (Rantala et al., 1999). The estimated current global prevalence of 
the MetS is nearly 16% (95% CI 10-23) (Wild et al., 2004). 44% of the U.S. population 
older than age 20 affects by MetS. A higher percentage of women older than age 50 have 
the syndrome than that of men (Ervin, 2006). Studies from Europe, North America, and 
Australia report the prevalence of the MetS to be between 12% and 25% (Sattaret al., 2003 
;Villegas et al., 2003 ; Cameron et al., 2003). While studies in Asia have mostly found a 
reduced prevalence of 5% (Holloszy et al., 1986; Lee et al., 2004). Using the 2005 version 
of NCEP-ATP III the prevalence of MetS in China, Taiwan Hong Kong and Thailand 
(Lohsoonthorn et al., 2006) was ranging from 10-15% (Feng et al., 2006). Otherwise, the 
rates in the Koreans were higher than the Chinese and Thai‘s even though their BMI was 
similar to other East Asia countries.  
The metabolic syndrome is common among Arab populations in Mediterranean countries 
(Abdul-Rahim et al., 2001; Al-Lawati et al., 2003) and among Arab Americans (Jaber et 
al., 2004). Using the ATP III diagnostic criteria, the prevalence of the MetS in Jordan was 
36.3% (28.7% among men and 40.9% among women). The authors found that low HDL 
cholesterol was the most common abnormality in men (62.7%), and abdominal obesity was 
the most common abnormality in women (69.1%). Men had significantly higher 
prevalence of hypertriglyceridemia and lower prevalence of abdominal obesity than 
women. This study exposed that all other metabolic abnormalities did not significantly 
differ by gender (Khader et al., 2005). 
A study performed in Qatar showed that the prevalence of MetS was 26.5% and 33.7% 
according to NCEP ATP III and IDF respectively. The prevalence of MetS by ATP III and 
IDF increased with age and BMI. In addition to that the prevalence of MetS was more 
common in women. Multivariate logistic regression analysis (ATP III and IDF) showed 
that age and BMI were significant contributors for MetS, Both definitions strongly 
confirmed age and obesity as associated factors for MetS (Bener et al., 2009). 
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A study conducted among patients with CVDs in Gaza estimated that the prevalence of 
MetS was 59.5%, without difference between male and female. The main risk factors for 
MetS were large WC (67.9%), high TG (78.6%), high FBS (86.4%), and high BP (78.8% 
for systolic and 73.8% for diastolic BP) (Jamee et al., 2013). 
Another study set up to evaluate the reliabilities of NCEP/ATP III and IDF definitions in 
diagnosing MetS among Gaza Strip Palestinians, The overall prevalence was 23.0% and 
39.5% according to NCEP/ATP III and IDF respectively (p < 0.001), the results showed 
there is no significant differences in the number of MetS components in individuals having 
MetS by either definition (mean 3.42 ± 0.63 vs 3.52 ± 0.69 respectively, p = 0.865). Both 
IDF and NCEP/ATP III showed an increased prevalence of MetS with age, and BMI, 
however they revealed different prevalence trends with sex. Except for BMI, there were no 
significant differences in the general and metabolic related characteristics between people 
with MetS of IDF and NCEP/ATP III definitions (Sirdah et al., 2012). 
The prevalence of the MetS using the IDF criteria in study done for people aged ≥ 40 years 
living in Tunis, Tunisia was 45.5%; 55.8% in women and 30.0% in men (P <0.001), 
greater than the rates of 28.7% (WHO) and 24.3% (NECP ATPIII) using the previous 
definitions. All definitions agreed that the prevalence was higher in women than in men 
because of significant differences in central obesity and HDL- cholesterol (Harzallah et al., 
2006). 
The metabolic syndrome was present in 4.6%, 22.4%, and 59.6% of normal-weight, 
overweight, and obese men, respectively, and a similar distribution was observed in 
women (Park et al., 2003). MetS was correlated positively with marital status, cessation of 
cigarette smoking, and negatively with the level of education, alcohol consumption, current 
cigarette use, household income, and physical activity. In their study, HTN was found to be 
the most common MetS component as (57.4%). In decreasing order were abdominal 
obesity (40.9%), low HDL-C (31.8%), hypertriglyceridemia (30.7%), and high fasting 
blood glucose levels (9.2%), where men had significantly higher prevalence of 
hypertriglyceridemia (36.2%) than women. The frequencies of abdominal obesity (57.6%) 
and low HDL (33.6%) concentration were higher in women than men (Erem et al., 2008). 
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2.4 Metabolic syndrome components 
2.4.1 Abdominal obesity 
Obesity, as defined by BMI > 30, is a strong risk factor for MetS (Ford et al.,  2002). It has 
been suggested by many studies that visceral obesity is more importance than somatic 
obesity. Various methods have been proposed to measure it; anthropometric measurements 
include the WC, waist-hip ratio (WHR), BMI (Zulfiqar & Ahmed, 2007). Though some 
criteria uses WC and other use BMI to estimate the excessive deposition of fat in the body. 
It has been found that WC and BMI are highly correlated and there‘s no superiority 
between the two.  
The association between weight-gain and rotating shift work has been explored. A 
systematic review  provided strong proof of the correlation between shift work and obesity. 
In addition to that, behavioral changes that associated with shift work, such as decreased 
physical activity, may independently lead to weight gain and the development of  MetS 
(Van Drongelenet et al., 2011). A study done by Di Lorenzo et al. showed that obesity was 
more prevalent in shift workers (20.0%) than in day workers (9.7%). Another hospital 
based study in Botswana showed that obesity (28.7%) and overweight (27.3%) were the 
major high risk factors for the MetS among healthcare workers (Kelliny et al., 2007). 
2.4.2 Dyslipidemia 
Dyslipidemia of the MetS, has been characterized by:  
1. Raised TG values (hypertriglyceridemia). 
2. Low HDL cholesterol values. 
3. Increased small, dense LDL values. (Ginsberg & Huang, 2000). 
It is believed that such ―atherogenic dyslipidemia‖ is associated with the MetS and 
contributes to accelerated atherosclerosis (Grundy, 1998). 
2.4.3 Hypertension 
Increased blood pressure is highly associates with obesity and commonly occurs in insulin-
resistant persons. Hence, HTN commonly listed among metabolic risk factors. However, 
some investigators believe that HTN is less "metabolic" than other MetS components. 
Certainly, HTN is multifactorial in origin. Even so, most conference participants favored 
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containment of elevated BP as one component of the MetS (Grundy et al., 2005). HTN 
have been suggested to correlate with insulin resistance (Wassink et al., 2007; Eckel et al., 
2005; Reaven, 1988). When insulin resistance is found, the vasodilatory effect of insulin 
(Westerbacka et al., 2001) in the endothelium will be suppressed resulting in 
vasoconstriction (Montagnani & Quon, 2000). Compensative hyperinsulinemia increases 
the activity of the sympathetic nervous system, where the effect on insulin action is 
conserved (Egan, 2003). The reabsorption of renal sodium in the kidney is elevated 
directly by fat tissue (Sharma et al., 2002) and via increased the activation of sympathetic 
nervous system. Moreover, free fatty acid (FFA) created by adipose tissue may directly 
facilitated vasoconstriction (Tripathy et al., 2003).  
2.4.4 Pathophysiology of metabolic syndrome 
The mechanisms in which the MetS is occurred are not fully known (Eckel et al., 2005), 
and there is debate regarding the initiating factor, which leads to MetS. The sedentary 
lifestyle has an important role in the development of MetS (Reaven, 1988; Park et al., 
2003). In addition, the genetic and environmental components have been implicated in the 
development of MetS. Among these, obesity and insulin resistance play an important role, 
and both coexist almost in a patient with MetS (Babu et al., 2005). 
2.4.4.1 Obesity and abnormal body fat distribution 
According to the criteria of IDF, MetS can also be called central obesity syndrome (Gary, 
2006). It is more metabolically active than peripheral fat. Recently, studies suggested that 
central adiposity is the first component to be developed and that weight reduction at that 
point could be the best way to prevent it. The WC can be measured to assess individuals 
for increased risk for insulin resistance related CVD, MetS and T2DM (Steele et al 2005; 
Pladevall et al., 2006). Although insulin resistance is known to be the major factor for the 
development of MetS, but it is suggested that obesity provides the connection between the 
insulin resistant, dyslipidemic and hypertensive factors (Wingard et al., 1996). Adipose 
tissue can define as a heterogeneous mixture of fat cells, immune cells, stromal 
preadipocytes, and endothelium (Halberg et al., 2008).  
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With progressive adipocytes enlargement and obesity, the blood supply to fat cell may be 
reduced with eventual decreased oxygen supply (Cinti et al., 2005). Hypoxia can be 
considers as spectacular etiology of necrosis and macrophage infiltration into adipose 
tissue that leads to an increased production of active metabolites known as adipocytokines 
that involved FFA, glycerol proinflammatory mediators (plasminogen activator inhibitor-1 
(PAI-1), tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)), and CRP (Lau et 
al., 2005). All of this will lead to localized inflammation in adipose tissue that proliferate 
all systemic inflammation associated with the development of obesity related comorbidities 
(Trayhurn & Wood , 2004). Additionally, visceral fat releases their metabolic products into 
portal circulation, which carries blood into the liver. Hence FFAs are poured into the liver 
and also accumulate in the pancreas, heart and other organs, lead to produce impaired 
regulation of insulin, blood sugar and cholesterol as well as abnormal heart functions. 
 The National Cholesterol Education Programme Adult Treatment Panel III suggested cut 
off of 102 cm (40 in) and 88 cm (35 in) for males and females as a marker of central 
obesity. Parikh et al. (2006) proposed that Index of central obesity, which is the ratio of 
WC and height, was a better alternative than the WC. Central obesity is correlated with 
both insulin resistance and T2DM itself (Gabriely et al., 2002). 
2.4.4.2 Insulin resistance and glucose intolerance 
Insulin resistance can be defined as an insufficient insulin action in liver, adipose tissue 
and skeletal muscle (Reaven, 2005). It appears to be the primary mediator of MetS (Lann 
& LeRoith, 2007). The metabolic effect involves the activation of phosphatidylinositol 3-
kinase. In case of Insulin resistance, phosphatidylinositol 3- kinase path is impaired and 
insulin is no longer antiatherogenic (Wang et al., 2004). Also, insulin resistance triggered 
the gluconeogenesis in the liver, reduced glucose disposal in the muscle, and increased the 
release of FFAs from the adipose tissue (Reaven, 2005).  
A reason of insulin resistance is related to obesity. Non esterified fatty acids (NEFAs) are 
released from excess adipose tissues, which increase insulin resistance (Eckel et al., 2005) 
by inhibiting insulin signaling (Wassink et al., 2007). Insulin prevents lipolysis in adipose 
tissue and glucose production in the liver (Jensen et al., 1989). Accordingly, when insulin 
resistance develops, the inhibitory effect of insulin on lipolysis is suppressed 
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 (Eckel et al., 2005). MetS is associated with a high amount of intra-abdominal fat 
(Salmenniemi et al., 2004).  
Other contributors to insulin resistance involve abnormalities in insulin secretion, insulin 
receptor signaling and impaired glucose disposal (Eckel et al., 2005). Furthermore, there is 
an increased production of inflammatory cytokines and decreased production of anti-
inflammatory adipokines (Ross, 1999; Eckel et al., 2005; Wassink et al., 2007; Cornier et 
al., 2008). This imbalanced production of inflammatory cytokines favors both the 
inflammatory state associated with obesity and induces insulin resistance by impairing 
insulin signaling transduction (Wassink et al., 2007). Study done by Reilly et al. (2004) 
proposed that insulin resistance or its biomarkers may lead to CVD in people with MetS. 
2.4.4.3 Dyslipidemia: 
Dyslipidemia in MetS characterized by high TG and low levels of HDL cholesterol. The 
elevated level of TG in the presence of insulin resistance results from increased circulating 
FFAs. As insulin resistance increases, the lipolysis inhibitory mechanisms of insulin on 
adipose tissue decrease and more FFAs are produced. In addition lipoprotein lipase is 
stimulated and increases the release of TG. Hypertriglyceridemia will cause alterations, 
both in structure and metabolism of HDL and LDL (Menuet et al., 2005). Obese 
individuals with MetS and dyslipidemia almost always have low HDL levels (Grundy, 
2004). The presence of low HDL cholesterol in MetS is partially due to high TG. 
 As triglycerides increase, the cholesterol esters of HDL are exchanged for TG through the 
action of cholesteryl ester protein, causing the HDL particle to become smaller and less 
dense. Across some mechanisms not well understood, the smaller HDL particle is 
metabolized at an abnormally high rate resulting in low HDL levels. This shift to smaller 
particles make them less anti-atherogenic, because the larger they are, the more free 
cholesterol they can remove from cells and atherosclerotic plaque (Menuet et al., 2005). 
Cholesterol of LDL fraction is often normal, but LDL particles are smaller and denser than 
normal, which is related to increase cardiovascular risk (Reilly & Rader, 2003). Smaller 
LDLs also increases the ability to penetrate the vascular endothelium and a greater affinity 
for intimal glycans. The retention in the intima allows for enhanced oxidative 
transformation, endovascular injury and the accumulation of foam cells (Menuet et al., 
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2005). In addition to increased numbers of smaller and denser LDL cholesterol particles, 
there is marked increase in apolipoprotein B. In fact, it appears that once apolipoprotein B 
concentrations increased, cardiovascular risk can be considered high (Sattar et al., 2004). 
2.4.4.4 Other factors 
Environmental and genetic factors have been implicated in the development of this 
syndrome. Older age, sedentary lifestyle, and high-fat diet can increase the prevalence of 
MetS. In the European Youth Heart Study, physical activity in children was inversely 
correlated with MetS risk factors (Brage et al., 2004). Similarly in the Amsterdam Growth 
and Health Longitudinal study, fat, fitness, and lifestyle were important determinants of 
MetS in young adults (Ferreira et al., 2005). 
 Decreased physical activity lowers the levels of the glucose transporter protein (GLUT-4) 
and can lead to high release of NEFA. High-fat diets, (Freire et al., 2005), high 
carbohydrate intake, (Ford et al., 2004) and empty-calorie eating pattern (Sonnenberg et 
al., 2005) were related to an increased risk for the development of MetS. In contrast, 
whole-grain intake, especially cereal fiber, (McKeown et al., 2004) and intake of linoleic 
acid, (Freire et al., 2005) were associated with a lower prevalence of MetS. 
2.5 Clinical manifestation of Metabolic Syndrome 
2.5.1 The risk of cardiovascular disease 
People with the MetS are at more risk of developing T2DM and CVD (Lakka et al., 2002; 
Gami et al., 2007; Mottillo et al., 2010). CHD, myocardial infarction and stroke are 
complications of MetS that consider the leading cause of all deaths in industrialized 
countries. Lakka et al. showed in a prospective study of Finnish men that CVD-death and 
all-cause mortality were increased in people with the MetS even in the absence of CVD or 
diabetes (Lakka et al., 2002). Botnia study on 4,483 middle-aged participants in Finland 
and Sweden found a marked elevated in cardiovascular mortality in participants with MetS 
during a 6.9-year follow-up period (12.0 vs 2.2%, P < 0.001) (Isomaa et al., 2001). 
A meta-analysis on the 87 studies that used NCEP or revised NCEP definitions confirmed 
that MetS is associated with a twofold increase in cardiovascular outcomes (Mottillo et al., 
2010). The relative risk was 2.35 (95% confidence interval [CI] 2.02–2.73) for all CVD, 
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2.40 (95% CI1.87–3.08) for CVD mortality, 1.99 (95% CI 1.61–2.46) for myocardial 
infarction and 2.27 (95% CI 1.80–2.85) for stroke. 
2.5.2 The risk of diabetes mellitus 
Type 2 diabetes consider the most common form of diabetes and is characterized by 
disturbances of insulin action and insulin secretion, either of which may be the 
predominant feature (WHO Department of Noncommunicable Disease Surveillance, 
1999). The development of T2DM arise from a failure of insulin producing cells to 
maintain the degree of compensatory hyperinsulinemia that is essential to prevent loss of 
glucose tolerance in insulin-resistant tissues thus leading to increased plasma levels of 
glucose (Gerstein, 1997; Stratton et al., 2000; Juutilainen et al., 2005). MetS is common in 
individuals with DM and significantly more common in patients with T2DM than in those 
with type 1 diabetes mellitus (Guzder et al., 2006; AlSaraj et al., 2009). Nearly all 
individuals with T2DM have MetS (Liese et al., 1998). 
People with MetS have a fivefold increased risk to develop T2DM and are in higher risk of 
morbidity and mortality from CVD, for this a combination of each risk factors, the 
interaction between MetS components occurs in a synergic manner to accelerate the 
development of atherosclerosis (Stern  et al., 2004). Ford et al. showed that the RR is 3.5-
5.2 (depending on ethnicity) for incident T2DM in people with the MetS compared to 
those without it (Ford et al., 2008). 
2.6 Shift work 
The council Directive in November 1993 concerning certain aspects of the organization of 
working time (as amended by Directive 2000/34 of 22 June 2000) defines shift work as 
method that organize work in shifts whereby workers succeed each other at the same work 
stations according to a certain pattern, including a rotating pattern, and which may be 
continuous or discontinuous, necessitating the need for workers to work at various times 
over a given period of days or weeks‖.  
Shift work have numerous definitions. Most studies assorted shift workers as anyone 
working outside regular daytime hours. According to this definition, shift workers include 
all people working evening shift, night shift, rotating shifts, or on-call schedules both 
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during the week and on weekends (Institute for Work and Health, 2003). The working 
hours of rotating shift workers, that do not harmonize with their daily life rhythms, cause 
negative effects on the health of rotating shift workers involve CVDs, as myocardial 
infarction and angina pectoris (Bøggild & Knutsson, 1999; Vyas et al., 2012); 
cerebrovascular diseases, such as stroke (Brown et al., 2009), arthritis, DM and MetS (De 
Bacquer et al., 2009). 
Many health problems are related to shift work, possibly due to an impairment of 
biological rhythm. Over the last decades, many countries have become 24-hour societies. 
As a result, the concerning about the influence of shift work on several health problems has 
been increasing all the time. Several studies have scrutinized the relationship between 
MetS and shift work and reporting a fivefold increase in the risk of developing MetS in 
shift workers compared with daytime workers (Pietroiusti et al., 2010). 
2.7 Circadian rhythm 
Circadian rhythms are essential physiological processes. They are found in all organisms, 
these daily rhythms, of period about 24 hours, are associated with periodic changes in 
hormones controlling sleep/attentiveness, body temperature, BP, heart rate and other 
physiological variables (Gonze et al., 2002; Leloup & Goldbetter, 2003). It has three main 
characteristics: it is resistant to sudden changes, endogenous, and adapt slowly to changing 
conditions. The main synchronizer of the human circadian rhythm is central nervous 
system (CNS), and coordinates circadian pacemakers in the brain and peripheral tissues 
through signals generated in the suprachiasmatic nucleus of the hypothalamus that align 
the circadian period and phase with external stimuli (Garaulet et al., 2010). 
We are a diurnal species and thus, we normally sleep at night and active through the 
daytime. The timing of functions with notable rhythms such as, metabolism, sleep, 
alertness and performance in a normal environment is such that they are optimal during the 
most suitable phase of the day. A sudden variation from ‗normal‘ timing of work and sleep 
can lead to problems, for example sleeping during the day is usually shorter and of worse 
quality than when taken at night (Akerstedt, 2005; Akerstedt et al., 2008). The circadian 
rhythm can become desynchronized in rotating shift workers whose night activity is out of 
phase leading to desynchronization of the normal phase (Klerman, 2005). 
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The circadian system regulates metabolism (Holzberg & Albrecht, 2003). There is 
increasing evidence correlates circadian desynchrony to disorders as MetS (central obesity 
,insulin resistance, increased BP, reduced HDL cholesterol, high TG (triacylglycerol, 
TAG) and CVD (Van Cauter et al., 2008). Interestingly, there is evidence that men are 
more susceptible to metabolic abnormalities than women. TAG considers an independent 
risk factor for development of heart disease (HD). This may provide a partial explanation 
for the elevated risk of HD in rotating shift workers. In large surveys, shift workers have 
increased TAG levels as well as elevated TC than daytime workers (Knutsson &  Boggild, 
2000; Biggi et al., 2008). 
2.8 Shift work and cardiovascular risk 
There is a growing concern about coronary artery disease and acute myocardial infarctions 
and their related with shift work, however, rotating shift work was not associated with all 
mortality and death (Vyas et al., 2012). A study performed in a public university in Brazil 
evaluated cardiovascular risk found that cardiovascular risk (28 %) was higher in night 
workers than in day workers (Pimenta et al., 2012). Another study performed to evaluate 
the effect of shift work on BP found that the systolic arterial pressure of night workers was 
2.5 mmHg (p < 0.001) higher than that of day workers (De Gaudemaris et al., 2011).  
A various prospective and retrospective studies, reported that shift workers were found to 
have a 40% CVD risk increase (Bøggild & Knutsson, 1999). Many studies suggest that 
impaired metabolic regulation due to change lifestyles, circadian rhythms and chronic 
work stress may partly elucidate the relationship between shift work and increased 
cardiovascular risk (Knutsson & Bøggild, 2000). 
2.9 Shift work and Diabetes mellitus 
Type 2 diabetes is a world-wide epidemic disease. It is a significant cause of morbidity and 
mortality and its consequences are an unbearable encumbrance to the individual and 
healthcare systems (WHO Department of Non-communicable Disease, 1999). The 
vigorous evidence correlating shift work and T2DM derives from epidemiological studies 
which show that shift workers are at increased risk for getting T2DM (Kroenke et al., 
2006; Pan et al., 2011). A study done by Suwazono et al. (2009) on male Japanese workers 
revealed that shift work was an independent risk factor for impaired glucose metabolism. 
27 
 
Also, Mikuni et al. (1983) reported a higher prevalence of DM among shift workers. 
Morikawa et al. (2005) suggests that shift work is a risk for the onset of DM. 
2.10 Shift work and metabolic syndrome 
Metabolic syndrome has been variously described (Cornier et al., 2008; Suwazono et al., 
2010), and the definition is essential to underlying pathophysiological processes. Higher 
prevalence of the MetS has been demonstrated among shift workers (Karlson et al., 2001; 
Esquirol et al., 2009). A study done by Sookoian et al. showed the risk of MetS was 1.5 
times higher among shift workers, taking into account age and physical activity (Sookoian 
et al., 2007). Another study using the new IDF score, which takes into account almost the 
same parameters but with different weights, the prevalence of the MetS was 37.1% among 
shift workers and 20.8% among day workers (P < 0.05) (Copertaro et al., 2008).  
Esquirol et al. show that shift work, regardless of models, was significantly correlated with 
MetS (De Bacquer et al., 2009). A recent study by De Bacquer et al. demonstrates that the 
risk of development of the MetS increases independently of the accumulated years of shift 
work. Rotating shift work has an influence on each component of MetS (Esquirol et al., 
2009) and the risk of developing MetS is high in night shift healthcare workers (Pietroiusti 
et al., 2010). 
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Table (‎2.2): Recent epidemiological studies on the relationship between shift work, CVD, DM and MetS 
Author 
Study 
design 
Population (age) Outcomes Main exposure Main results 
Karlsson et al., 
2001 
Cross-
sectional 
F: 4632 shift workers, 9857 day 
workers; M: 3277shift workers,9719 
day workers (aged 30, 40, 50,or 60) 
Metabolic syndrome Shift work/day work F: RR = 1.71 (P < 0.0001); M: RR 
=1.63 (P< .0001) of having all  
three  components(obesity, 
hypertension, and high 
triglycerides) 
Nagaya et al., 
2002 
Cross-
sectional 
M: 826 shift workers, 2824 day 
workers (46.7 +/- 7.0 years) 
Fasting serum 
glucose>7.00mmol/l 
Shift work/day work Age group 30–39years OR = 
6.75(95% CI 1.31–
56.1);agegroup40-49 years 
OR=1.22(95% CI 0.68–
2.10);Agegroup50–59 years OR = 
0.93(95%CI0.53–1.55) 
Haupt et al., 
2008 
Cross-
sectional 
F: 1052unexposed, 192exposed; M: 
760unexposed,506 exposed (mean 
age: 61.5unexposed, 62.3exposed) 
Atherosclerosis and 
MI 
Exposed to shift 
work/unexposed 
HR = 1.53 (95%CI 1.06–2.22) of 
MI at an early age 
Esquirol et al., 
2009 
Cross-
sectional 
M: 100 shift workers; 98 day workers 
(mean age: 46.54 shift workers; 48.84 
day workers) 
Metabolic 
syndrome(NCEP-
ATPIII and IDF 
definitions) 
Rotating shift work/day 
work 
OR = 2.38 (95%CI 1.13–
4.98)(NCEP-ATPIII);OR = 0.95 
(95%CI 0.51–1.78)(IDF) 
Brown et al., 
2009 
Cohort F: 28 015 never,36 400(1–14) 
years,3821 (15–29) years,1187 >30 
years mean age: never 54.555.0 (1–14 
years), 56.3(15–29 years),60.4 (>30 
years)] 
 
Ischemic stroke Rotating night shift/day 
time and evenings  
HR = 1.04 (95%CI 1.01–1.07)of 
ischemic stroke per 5 years 
working rotating night shifts 
Pietroiusti et 
al., 2010 
Cohort F: 244 day workers,278 night 
workers; M: 92 day workers, 124 
night workers (mean age: 38.9 shift 
workers; 37.9daytime workers) 
Metabolic 
syndrome(updated 
NCEP definition) 
Night shift work or 
rotating shift work(at 
least four nights per 
month during a 
year)/daytime work 
RR = 5.10 (95%CI 2.15–12.11) 
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2.11 Shift work and inflammation 
Shift work has been to contribute to the elevated hazard for sleeping difficulties and other 
diseases such as CHD and HTN (Hampton et al., 1996; Ha and Park, 2005). Sleep 
disturbances caused by shift work may play an important role in enhancing inflammation 
and thus leading to coronary artery disease. CRP observed to be a typical pointer of 
inflammation (Albert & Ridker, 2004). Brand new studies have reported an association 
between inflammation and thrombogenesis as potential causes for CVD in patients 
suffering from the MetS (Hansson, 2005).  
Additionally, there is a positive correlation between increased leukocyte count and risk of 
CHD suggesting that leukocyte count is related with MetS, so it was presumed that 
increased white blood cell (WBC) may be another component of it (Targher et al., 1996). 
Furthermore, it has been demonstrated that regardless the presence of the MetS in an 
individual, CRP levels independently portend the occurrence of CVD (Ridker et al., 2003). 
Because the MetS has been linked with a greater chance of CVD, CRP levels may be an 
independent predictor of undesirable outcomes in the MetS (Clearfield, 2005). 
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3 Chapter (3) 
Methodology 
This chapter described the methodology of the study. It is defined as the way in which 
relevant information is gathered in order to answer the research questions or analyze the 
research problem including research approach, research design, instrument modifications, 
recruitment sample, study population, eligibility criteria, pilot study, data collection 
procedure and plan for data analysis, ethical and administrative approval. Finally it 
described limitation of the study. 
3.1 Study design  
This study is quantitative approach; the design is comparative analytical cross sectional 
that use to determine the prevalence and effect of rotating shift work on biomarkers of 
MetS and inflammation. A cross sectional study is usually rapid, quick, cheap, and easily 
undertaken. It is generally carried out at a point of time or over a short period. In addition, 
it gives more insight into the association between variables in the study. However, it is 
limited by the fact that it is carried out at one point and gives no indication of the sequence 
of events whether exposure occurred before, after or during the onset of the disease 
outcome. This being so, it is impossible to infer causality (Levin, 2006). 
3.2 Study setting 
This study was conducted in two governmental hospitals, Al-Shifa Hospital (ASH) and Al- 
Nassir Pediatric Hospital (ANPH). The researcher chose these hospitals for several reasons 
including the following: the ASH hospital is the largest and general hospital in the Gaza 
strip, has the largest number of rotating shift health care workers (approximately 714), and 
is located in the Gaza city. ANPH hospital is one of the main general pediatric hospitals 
that located in the Gaza city and has nearly 141 rotating shift health care workers.  
3.3 Study population 
The study population consisted of health care workers who work in these aforementioned 
selected hospitals in total 1474 healthcare workers (1268 from ASH and 206 from ANPH)  
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 including physicians (470 from ASH, 55 from ANPH), nurses (680 from ASH, 120 from 
ANPH), medical technologists, radiologists, and radiologic technologists (118 from ASH, 
31 from ANPH).  
3.4 Eligibility criteria 
3.4.1 Inclusion criteria 
It included rotating night shift and daytime health care workers (male and female) in ASH 
and ANPH hospitals. 
3.4.2 Exclusion criteria 
1- Permanent night shift health care workers at the selected hospitals. 
2- Health care workers with previous T2DM, CVD, and inflammatory disease. 
3- Health care workers with type1 diabetes mellitus. 
4- Health care workers with familial hyperlipidemia. 
3.5 Period of the study 
The study took 10 month in execution; it started in April, 2016 and completed by February 
2017. This study was initially proposed in April, 2016. The research proposal has been 
submitted to and defended in the front of SOPH assigned committee in May 2016. At its 
development, the research proposal described the entire process and provided information 
and design of the data collection and data analysis methods and tools. Upon the approval, 
the researcher prepared the required tools of his study in addition to the demographic 
question. The researcher has consulted a group of 12 experts at arbitration stage before the 
finalization of the tool. The arbitration stage lasted for two weeks including refining of 
tools in the light of reviewers and the academic supervisor's feedback. 
In October 2016, the tool was ready to go for data collection. Piloting took place between 2 
and 6 October 2016. Actual data collection started on 16 October through 30November 
2016. The researcher identified daily work hours to start at 07.15 am through 01.00 pm in 
order to increase the likelihood of distributing the questionnaires as many participants as 
possible. 
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Initial analysis of quantitative data was done between December 2016 - January 2017. The 
researcher extracted findings, created descriptive tables and performed inferential 
statistical analysis. The drafted report "thesis" has been frequently enriched and edited by 
the research supervisor. The final draft for defense was handed on 30March, 2017.  
3.6 Sampling 
The sampling frame was from the governmental hospitals (Al- Shifa Hospital and Al- 
Nassir Pediatric Hospital). 
Convenient sampling method was proposed because the mentioned hospitals consider the 
main and largest hospitals and nearly has the largest number of health care workers.  
3.7 Sample size and sample process 
In order to calculate the required sample, the researcher gathering the needed data, as 
shown in Annex 10. The researcher used Epi –Info version 7 to calculate the sample size 
(Annex 1), the number of all healthcare workers (physicians, nurses, radiologists, 
radiologic technologists and, medical technologists) work at ASH and ANPH are 
nearly1474. The highest estimate of sample size was when both categories exposed and 
non-exposed reporting the outcome with 50%, and by considering the confidence interval 
was 95%, the power was 80, so the sample size was 305 health care workers. To overcome 
non-respondents, 310 health care workers were including in the study. The sampling of 
Self-administering questionnaire includes two governmental hospitals in the Gaza Strip 
(ASH and ANPH), then proportional sample was chosen from each health care workers in 
the two selected hospitals according to their number (Annex 10). 
3.8 Research instrument 
In this study the researcher used 2 main types of instruments: 
3.8.1 Direct instrument 
• Self-administering questionnaire 
Self-administering questionnaire administered to health care worker in the selected 
hospitals. Most questions were the yes/no questions, which offer a dichotomous choice. 
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The questionnaire includes questions on the personal data (sex, age, occupation, 
household, income). The questions covered social data, demographic data, medical history 
to detect the presence of diseases as HTN, CHD, DM and inflammation, life style variables 
such as (physical activity, and smoking), and the occupational history including questions 
about shift work (Annex 5). 
3.8.2 Laboratory investigations and clinical tests 
• Biochemical tests were measured from serum sample using chemistry kits in 
spectrophotometer including: 
1- Triglyceride 
2- HDL, LDL, Cholesterol 
3- Fasting Blood glucose 
4- CRP 
 
•  CBC 
 
• Anthropometric measurements including: 
 length 
 weight  
 
• Blood pressure 
3.9 Standardization of measurements:  
The researcher used three calibrated and standardized electrical balance (TANITA, Japan), 
(DETECTO, Japan) from ASH and (DETECTO, Japan) from ANPH. The body weight of 
each participant dressed in light clothing without shoes was measured, then the height of 
each individual was measured using vertical measuring rod. BMI was calculated as weight 
(kg) divided by squared height (m
2
). After a 5 minutes rest at minimum, systolic and 
diastolic arterial BP was measured on the right arm with a standard mercury 
sphygmomanometer at sitting position (RIESTER, Germany). 
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3.10 Data and sample collection 
Data collection is defined as the precise, systematic gathering of information related to the 
research purpose or specific objectives, questions, or hypothesis of the study (Burns & 
Grove, 2003). The health examinations included anthropometric measurements, a 
questionnaire on health-related behaviors and biochemical determinations, information 
about the years of work, either shift work or day work duration and past medical history 
was included. Overnight fasting for at least 10 hours required prior to blood sampling for 
all participants who agreed to be included in the study. Venous blood samples (5 ml) were 
collected from the fasting individuals in serum vacutainer tubes without anticoagulant, and 
EDTA tubes for CBC tesy under quality control and safety procedure. The serum was 
separated from blood samples by centrifugation at 3500-4000 rpm for 10 min. The 
separated serum was placed in new plain tubes and sealed for biochemical analysis. Blood 
in EDTA tube was used to measure leukocyte count and its differential count. 
3.10.1 Biochemical analysis 
Serum levels of: TC, HDL and LDL cholesterol, TG, fasting glucose, and CRP were 
measured automatically by (Respons 920 DiaSys, Germany) using commercially analytical 
kits (DiaSys, Germany).  
3.10.1.1 Determination of serum glucose 
Serum glucose was determined by glucose oxidase (GOD)/glucose peroxidase (POD) 
method (Trinder, 1969) using analytical kits (DiaSys, Germany). 
Principle:  
Glucose oxidase catalyses the oxidation of glucose to gluconic acid. The formed hydrogen 
peroxide (H2O2) is detected by a chromogenic oxygen acceptor, phenolaminophenazone 
in the presence of POD. 
Â-D-Glucose + 2H2O + O2      GOD       Gluconic acid + H2O2 
H2O2 + Phenol + 4-Aminophenazone (4-AP)   POD       Quinone + H2O 
The intensity of the red color formed is proportional to glucose concentration in the 
sample. 
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Reagents Composition 
Reagent Component Concentration 
Reagent 1 TRIS pH 74 
Phenol 
GOD 
POD 
4-AP 
92 mmol/L 
0.3 mmol/L 
15000 U/L 
1000 U/L 
2.6 mmol/L 
Assay procedure: 
Wavelength 340 nm, Hg 334 nm, Hg 365 nm 
Optical path 1 cm 
Temperature 20 – 25 °C 
Measurement Against reagent blank 
Mix, incubate 10 min. at 20 – 25 °C. Read absorbance against reagent blank within 30 min. 
Calculations: 
Glucose (mg\dl) = (Absorbance of sample / Absorbance of standard)   x   100 standard          
Reference values: Serum or plasma     70-110 mg/dl 
3.10.1.2 Determination of serum cholesterol 
Serum cholesterol was determined by cholesterol oxidase ―CHOD-PAP‖ method 
(Meiatlini et al., 1978) using analytical kits (DiaSys, Germany). 
 
 Blank Standard or sample 
Sample or Standard -- 10μL 
Dist. Water 10 Μl -- 
Mono-reagent 1000 μL 1000 μL 
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Principle: 
Determination of cholesterol after enzymatic hydrolysis and oxidation (Artiss & Zak, 
1997; Deeg & Ziegenhorn, 1983). The colorimetric indicator is quinoneimine which is 
generated from 4-aminoantipyrine and phenol by hydrogenperoxide under the catalytic 
action of POD (Trinder‘s reaction). (Artiss & Zak, 1997). 
Cholesterol ester + H2O     Cholesterol esterase (CHE)       Cholesterol + Fatty acid 
Cholesterol + O2    CHO      Cholesterol-3-one + H2O2 
2H2O2 + 4-Aminoantipyrine + Phenol   POD     Quinoneimine + 4H2O 
Reagent Composition: 
Assay Procedure: 
Wavelength 500 nm, Hg 546 nm 
Optical path 1 cm 
Temperature 20 – 25°C 
Measurement Against reagent blank 
 
 
 
Reagent Component Concentration 
Reagent 1 Good's buffer    pH 6.7           
Phenol  
4-Aminoantipyrine Cholesterol 
esterase   
CHO  
POD  
50 mmol/L  
5 mmol/L  
0.3 mmol/L 
> 200 U/L 
> 50 U/L 
> 3 kU/L4-AP 
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Mix, incubate for 20 min. at 20 – 25°C. Read absorbance within 60 min against reagent 
blank. 
Calculations: 
Cholesterol (mg\dl) = (Absorbance of sample / Absorbance of  standard) x Con. of 
standard 
Reference Range: 
Desirable <200 mg/dL  
Borderline high risk 200 – 240 mg/dL  
High risk > 240 mg/dL  
3.10.1.3 Determination of high density lipoproteins (HDL-C) 
High density lipoprotein cholesterol was determined by precipitating method (Grove, 
1979) using analytical kits (DiaSys, Germany). 
Principle 
The chylomicrons, very low density lipoprotein, and LDL-C from serum or plasma are 
precipitated by phosphotungstate in the presence of magnesium ions. After removed by 
centrifugation the clear supernatant is containing HDL-C and used for the determination of 
it. 
 
 
 
 
 Blank Sample or standard 
Sample or standard --- 10 μL 
Dist. Water 10 Μl -- 
Reagent 1000 Μl 1000 μL 
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Reagent Composition 
Reagent Component Concentration 
Reagent 1 Phosphotungstic acid 
Magnesium chloride 
14 mmol/L 
2 mmol/L 
Assay Procedure for Analyzer: 
Wavelength 600/700 nm (bichromatic measurement) 
Optical path 1 cm 
Temperature 37 °C 
Measurement Against reagent blank 
 
Calculation: 
HDL Cholesterol (mg/dL) (Absorbance of sample / Absorbance of  standard) x Con. of 
standard 
Reference Range  
 >35 mg/dL  
3.10.1.4 Calculation of low density lipoprotein (LDL) 
Low density lipoprotein was calculated using the Friedewald equation.   
Principle 
The ultra-centrifugal measurement of LDL-C is time consuming and expensive and 
requires special equipment. For this reason, LDL-C is most commonly estimated from 
 Blank Sample or calibrator 
Sample or calibrator --- 2.4 μL 
Reagent 1 240 μL 240 μL 
Mix, incubate 5 min. at 37°C, read absorbance A1, t hen add: 
Reagent 2 60 Μl 60 μL 
Mix, incubate for 5 min. at 37°C, read absorbance A 2. 
39 
 
quantitative measurements of total and HDL-cholesterol and plasma TG using the 
empirical relationship of Friedewald (Friedewald et al., 1972).    
The equation 
LDL-C = Total Cholesterol – (VLDL + HDL-C).  
VLDL cholesterol (mg/dl) =T.G/5 
Limitation 
The Friedewald equation should not be used when chylomicrons are present, and when 
plasma TG concentration exceeds 400 mg/dl. 
3.10.1.5 Determination of serum triglyceride 
Serum triglyceride was determined by Colorimetric enzymatic test using glycerol-3-
phosphate-oxidase . 
Principle 
Determination of triglycerides after enzymatic splitting with lipoprotein lipase (LPL). 
Indicator is quinoneimine which is generated from 4-aminoantipyrine and 4-chlorophenol 
by hydrogen peroxide under the catalytic action of POD.  
Triglycerides     LPL    Glycerol + fatty acid 
Glycerol + ATP    Glycerokinase (GK)   Glycerol-3-phosphate + ADP 
Glycerol-3-phosphate+O2 Glycerol-3-phosphate-oxidase Dihydroxyaceton phosphate + 
H2O2 
2 H2O2 + Aminoantipyrine + 4-Chlorophenol    POD      Quinoneimine + HCl + 4 H2O 
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Reagents Composition: 
Reagent Component Concentration 
Reagent 
 
Good's buffer pH 7.2  
4-Chlorophenol  
ATP  
Mg2+  
GK 
POD 
LPL 
Aminoantipyrine  
Glycerol-3-phosphate-oxidase  
50 mmol/L  
4 mmol/L  
2 mmol/L 
15 mmol/L 
 0.4 kU/L 
2 kU/L 
2 kU/L 
0.5 mmol/L 
0.5 kU/L 
Standard  200 mg/dL  
 
Assay Procedure: 
 
Wavelength 500 nm, Hg 546 nm 
Optical path 1 cm 
Temperature 20 – 25°C 
Measurement Against reagent blank 
Mix, incubate for 20 min. at 20 – 25°C. Read absorbance within 60 min against reagent 
blank. 
 Blank Sample or standard 
Sample or standard --- 10 μL 
Dist. Water 10 Μl -- 
Reagent 1000 μL 1000 μL 
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Calculation: 
Triglyceride (mg\dl) = (Absorbance of sample / Absorbance of  standard) x Con. of 
standard 
Reference Range: 
Desirable <200 mg/dL  
Borderline high risk 200 – 400 mg/dL  
Elevated > 400 mg/dL  
3.10.1.6 Determination of C-Reactive Protein (CRP) 
C- reactive protein was determined by Immunoturbidimetric method using analytical kits 
(DiaSys, Germany). 
Principle: 
Determination of CRP concentration by photometric measurement of the antigen-antibody 
reaction of antibodies to human CRP with CRP present in the sample. 
Reagent Composition 
Reagent Component PH Concentration 
Reagent 1 TRIS pH 7.5 100 mmol/L 
Reagent 2 TRIS pH 8.0 100 mmol/L 
Assay Procedure: 
Wavelength 340 nm, Hg 334 nm 
Optical path 1 cm 
Temperature 37°C 
 Measurement Against reagent blank 
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Reference Range:    Adults < 5 mg/L 
3.10.2  Complete Blood Count measurement: 
Leukocyte count and its differential counts (neutrophil and lymphocyte) were measured 
automatically by Orphee mythic 18 equipment, Sweden. 
3.11 Diagnostic criteria for the MetS 
For the diagnostic criteria of MetS, we used the NCEP/ ATPIII definition . The syndrome 
was met if an individual had three or more criteria:  
1- Waist circumference >102cm in men and >88cm in women 
2- Fasting plasma glucose ≥110mg/dl. 
3- Blood pressure ≥130/85 mmHg  
4-Serum triglycerides ≥ 150mg/dl  
5-Serum HDL cholesterol <40mg/dl in male and <50mg/dl in female.  
Because the participants refused to measure the WC , we measured the BMI instead of it 
for obesity, in which the participant considered obese if BMI >30. 
 
 
 
 Blank Sample or calibrator 
Sample or calibrator --- 15 μL 
Dist. Water 15 μL -- 
Reagent 1 250 μL 250 μL 
Mix, incubate 5 min. at 37°C, read absorbance A1, then add: 
Reagent 2 50 μL 50 μL 
Mix, incubate for 5 min. at 37°C, read absorbance A2. 
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3.12 Ethical and administrative consideration 
The researcher committed to all ethical considerations required to conduct a research 
which include: 
• An official letter of approval was obtained from public health school at Al Quds 
University. (Annex 7). 
• An official letter of request was obtained from the general director of MOH in Gaza 
Strip. (Annex 8). 
• An official letter of approval to conduct this study was obtained from the Helsinki 
Committee in the Gaza Strip (Annex 6) 
• To guarantee participants rights, a covering letter indicating that the participation is 
voluntary and the right to refuse was preserved. (Annex 4) 
• The confidentiality of the responses from the respondents was assured by explaining 
how the information shall be recorded and used. 
3.13  Pilot study 
Before starting the actual data collection process, a pilot study of 20 health care workers 
outside the selected clinics was done prior to the beginning of data collection to check 
applicability, identify problems in research questionnaire of data collection for validity and 
reliability. Pilot study was used to examine the clarity and ambiguity, length and suitability 
of questions before the data collection process starts (Polit & Beck, 2004). 
3.14 Reliability and Validity 
3.14.1 Reliability: 
Reliability is referred to repeatability or how far the investigator will repeat the same 
measurement if the investigation are conducted more than one time. Last defined reliability 
as "the degree of stability exhibited when a measurement is repeated under identical 
conditions". Reliability refers to the degree to which a measurement procedure can be 
replicated (last, 1983). 
The researcher regarded reliability of the instruments as an important issue and ensured it 
through filling the whole number of questionnaires; the researcher leaved clear instruction 
for in data collection. The same tools were used for all respondents and after data 
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collection completion; all filled forms were checked for completeness. Tool and 
implementation are standardized. 
3.14.2 Validity 
Validity refers to the degree to which a study accurately reflects or assesses the specific 
concept that the researcher is attempting to measure. While reliability is concerned with the 
accuracy of the actual measuring instrument or procedure, validity is concerned with the 
study's success at measuring what the researchers set out to measure. 
3.14.3 Face validity 
It is concerned with how a measure or procedure appears. Does it seem like a reasonable 
way to gain the information the researchers are attempting to obtain? Does it seem well 
designed? Does it seem as though it will work reliably? Unlike content validity, face 
validity does not depend on established theories for support (Fink, 1995). The study tools 
were checked for face validity when the pilot study was conducted. The researcher asked 
the pilot study respondents to give their opinions about the format, layout, structure and 
type-writing clarity of study instruments. 
3.14.4 Content validity 
Content validity is defined as the extent to which a test reflects the variables it seeks to 
measure (Holm & Liewellyn, 1986). The interviewed questionnaire was sent by the 
researcher to 12 experts to assess the instrument from clarity, relevancy to the topic and 
holism point of view. The experts have a good experience in field of medicine, public 
health, management and research. Those experts were asked to add any suggested 
modifications that will enrich the research tools. Their suggestions and comments were 
considered and modifications were introduced. Since instrument measures what is 
supposed to measure (Polit & Beck, 2004).  
3.15 Data entry 
After checking and reviewing all filled questionnaires on the same way, data were entered 
in the computer using SPSS (Statistical Package for Social Science) software version 20 to 
be analyzed. After finishing the data entry process, check codes were used to avoid double 
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entries. Pretesting of the tools were done to eliminate inconsistencies and made the 
questions relate to the local settings. Data cleaning were done to account for missing 
values in a bid to ensure integrity and reliability. 
3.16 Data analysis 
The collected data were captured and analyzed using SPSS (Statistical Package for Social 
Sciences) version 20. Frequencies and cross tabulations were used to do the data analysis. 
First, data cleaning were done to ensure that all data entered accurately and in appropriate 
way. Data cleaning were conducted through selecting and checking out of a random 
number of the filled questionnaires, and also through operating frequencies and descriptive 
statistics for almost all dependent and independent variables. Inferential statistical tests as 
Chi square, t-test, Fisher-exact x2 test, and Odds ratio were applied. The level of significance 
was set at a P value of less than 0.05. 
3.17 Limitation of the study 
1- Lack of resources including budget and facilities. 
2- Time limitation because of the nature of researcher work and life condition. 
3- The study did not include the NGOs and the private sectors. 
4- Matching was not possible due to the fact that the age of healthcare workers who 
work currently day shift is different from rotating shift. 
5- Comparative group was not selected from other places in which we can exclude the 
fact that employee had work previously in rotating shift which in fact introduce bias 
to the study. 
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4 Chapter (4) 
Results and Discussion 
 
This chapter presents the main results of our findings that collected by self- administering 
questionnaire and laboratory tests. In the descriptive analysis the percentage distribution 
provides a description of data including socio demographic characteristic, medical history, 
lifestyle, and natural of work of health care workers. Inferential analysis used to illustrate 
different determinants affecting MetS. The results were based on 310 self-administering 
questionnaire, all the respondents consented to the administered questionnaire giving a 
response rate of 100%. 
The results of this study could help the researcher in raising and suggesting the 
recommendations that could reduce the risk factors of MetS among health care workers 
(daytime and rotating shift workers). 
4.1 Descriptive statistics of Self-administering Questionnaires 
4.1.1 Socio-Demographic Characteristics of the Study Population: 
The represented sample of the health care workers included in the study was 310 
healthcare workers who were distributed in regard to selected hospitals and socio-
demographic characteristics including, gender, marital status, age, job, governorate, 
residence, and monthly income as shown in Table 4.1. The study sample consisted of 310 
healthcare workers who work at ASH and ANPH in the Gaza Strip, where (100) were 
currently day time workers (32.3%), and (210) were rotating shift workers (67.7%). The 
socio-demographic characteristics of participants were depicted in table (4.1). 
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Table (‎4.1): Distribution of the study population by socio demographic characteristics  
(N= 310) 
Variable Category 
Current 
daytime  
workers 
(N=100, 
32.3%) 
Rotating shift 
workers 
(N=210, 
67.7%) 
Total 
(N=310, 100%) 
N % N % N % 
Gender 
Male 56 56.0% 156 74.3% 212 68.4% 
Female 44 44.0% 54 25.7% 98 31.6% 
Marital status 
Single 19 19.0% 48 22.9% 67 21.6% 
Married 81 81.0% 162 77.1% 243 78.4% 
Age 
30 years & less 17 17.0% 99 47.1% 116 37.4% 
31-40 years 31 31.0% 68 32.4% 99 31.9% 
41 years & 
above 
52 52.0% 43 20.5% 95 30.6% 
Job 
physicians 31 31.0% 91 43.3% 122 39.4% 
Practical 
nursing 
51 51.0% 105 50.0% 156 50.3% 
Radiologists, 
radiologic 
technologists, 
and  medical 
technologists 
18 18.0% 14 6.7% 32 10.3% 
Governorate 
North 13 13.0% 30 14.3% 43 13.9% 
Gaza 72 72.0% 147 70.0% 219 70.6% 
Middle zone 14 14.0% 29 13.8% 43 13.9% 
Khan Younis 1 1.0% 3 1.4% 4 1.3% 
Rafah 0 0.0% 1 .5% 1 .3% 
Residence 
City 74 74.0% 157 74.8% 231 74.5% 
Village 3 3.0% 9 4.3% 12 3.9% 
Camp 23 23.0% 44 21.0% 67 21.6% 
Monthly income 
Less than 1000 
NIS 
9 9.0% 28 13.3% 37 11.9% 
1000 - 2000 
NIS 
22 22.0% 90 42.9% 112 36.1% 
More than 2000 
NIS 
69 69.0% 92 43.8% 161 51.9% 
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A total of 310 healthcare workers who work at ASH and ANPH in the Gaza Strip were 
included in this study, where (100) were currently day time workers (32.3%), and (210) 
were rotating shift workers (67.7%). The socio-demographic characteristics of participants 
were depicted in table (4.1).  
The majority of day time and rotating shift workers were males and married with percent 
(56.0%vs.74.3%), (81.0%vs.77.1%) respectively. A greater part of daytime workers were 
41 years and above (52.0% ), however 47.1% of rotating shift workers were 30 years and 
less. 
According to the profession, 51.0% of daytime workers were practical nursing, 31.0% 
were physicians, while 18.0% were radiologists, radiologic technologists, and medical 
technologists, and for the rotating shift workers, 50.0% were practical nursing, 43.3% were 
physicians, while 6.7%, were radiologists, radiologic technologists, and medical 
technologists. Most daytime and rotating shift workers lived in city and from Gaza with 
percent of (72.0% vs.70.0%) respectively, while (13.0% vs.14.3%) respectively from 
North area, and (14.0% vs. 13.8%) from middles zone respectively. Only (1.0% vs.1.4%) 
were from Khan Younis. 
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4.1.2 Occupational history of healthcare workers 
Table (‎4.2): Distribution of the study population by the natural work (N= 310) 
Variable Category 
Current 
daytime  
workers 
Rotating 
shift 
workers 
Total 
(N=100, 
32.3%) 
(N=210, 
67.7%) 
(N=310, 
100%) 
N % N % N % 
Have you ever had 
any nightshift work 
previously? 
Always 52 52.0% 183 87.1% 235 75.8% 
Sometimes 30 30.0% 22 10.5% 52 16.8% 
No 18 18.0% 5 2.4% 23 7.4% 
What departments 
do you spend most 
of the nightshifts in? 
Children 
department 
24 24.0% 54 25.7% 78 25.2% 
Surgery 
department 
26 26.0% 57 27.1% 83 26.8% 
Intensive care 
department 
11 11.0% 21 10.0% 32 10.3% 
Reception & 
emergency 
department 
10 10.0% 51 24.3% 61 19.7% 
Maternity 
department 
14 14.0% 15 7.1% 29 9.4% 
Other 15 15.0% 12 5.7% 27 8.7% 
Other departments 
Radiology 5 35.7 4 33.3 9 34.6% 
Laboratory 9 64.3 7 58.3 16 61.5% 
Burns 
department 
0 - 1 8.3 1 3.8% 
How many years did 
you have nightshifts 
work ? 
not exposed 17 17.0% 5 2.4% 22 7.1% 
1-5 years 21 21.0% 86 41.0% 107 34.5% 
more than 5 
years 
62 62.0% 119 56.7% 181 58.4% 
More than 5 years 
6- 10 years 22 35.5% 78 66.1% 100 55.6% 
11- 15 years 28 45.2% 30 25.4% 58 32.2% 
16 years and 
above 
12 19.4% 10 8.5% 22 12.2% 
How many shifts do 
you have monthly? 
not exposed 100 
100.0
% 
11 5.2% 111 35.8% 
1-5 shifts 0 0.0% 139 66.2% 139 44.8% 
More than 5 
shifts 
0 0.0% 60 28.6% 60 19.4% 
Previously in their career (nearly before more than ten years), there were 52.0% of the 
daytime workers had nightshifts, while 30.0% of them were sometimes got nightshifts, 
and18.0% had not nightshifts work previously. Currently they haven‘t nightshifts, 
Moreover; most of study population spent their nightshift at surgery department, followed 
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by children department, reception & emergency department, intensive care department, 
maternity department, other departments such as laboratory, radiology and Burns 
department (26.8%, 25.2%, 19.7%, 10.3 %, 9.4%, and 8.7% respectively). 
Our results showed that 62.0%  of daytime workers previously had nightshifts for more 
than 5 years (45.2% of them had a nightshifts  for11 to 15 years, 35.5% for 6 to 10 years 
and 19.4% for 16 years and above), 17.0% had not nightshift work previously, 21.0% had 
previously nightshifts from one year to 5 years, while 56.7% of the rotating shift workers 
have nightshifts work for more than 5 years, (66.1% of them have nightshift works for 6 to 
10 years, 25.4% for 11 to 15 years and 8.5% for more than16 years), while, 41.0% of them 
have nightshifts from one year to five years, 2.4% haven‘t nightshift work currently.  
Currently (for more than ten years up to now) the daytime workers haven‘t rotating shifts, 
while most of rotating shift workers with 66.2% have 1-5 nightshifts monthly, 28.6% have 
more than 5 shifts monthly, and 5.2% haven‘t nightshifts (they have morning and evening 
only).  
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4.1.3 Medical history of participants and their families 
Table (‎4.3): Distribution of the study population by health problems and medical history 
of their families (N= 310) 
Variable Category 
Current 
daytime  
workers 
(N=100, 
32.3%) 
Rotating 
shift workers 
(N=210, 
67.7%) 
Total 
(N=310, 100%) 
N % N % N % 
Diabetes (DM) 
Yes 17 17.0% 22 10.5% 39 12.6% 
No 83 83.0% 188 89.5% 271 87.4% 
Family history(DM) Yes 49 49.0% 90 42.9% 139 44.8% 
No 51 51.0% 120 57.1% 171 55.2% 
Heart disease (HD) 
Yes 6 6.0% 6 2.9% 12 3.9% 
No 94 94.0% 204 97.1% 298 96.1% 
Family history (HD) Yes 23 23.0% 50 23.8% 73 23.5% 
No 77 77.0% 160 76.2% 237 76.5% 
T. Cholesterol (TC) 
Yes 33 33.0% 44 21.0% 77 24.8% 
No 67 67.0% 166 79.0% 233 75.2% 
Family history (TC) Yes 19 19.0% 56 26.7% 75 24.2% 
No 81 81.0% 154 73.3% 235 75.8% 
Triglyceride (TG) 
Yes 41 41.0% 69 32.9% 110 35.5% 
No 59 59.0% 141 67.1% 200 64.5% 
Family history (TG) Yes 18 18.0% 45 21.4% 63 20.3% 
No 82 82.0% 165 78.6% 247 79.7% 
Hypertension(HTN) 
Yes 16 16.0% 23 11.0% 39 12.6% 
No 84 84.0% 187 89.0% 271 87.4% 
Family history (HTN) Yes 53 53.0% 111 52.9% 164 52.9% 
No 47 47.0% 99 47.1% 146 47.1% 
Chronic inflammation Yes 48 48.0% 124 59.0% 172 55.5% 
No 52 52.0% 86 41.0% 138 44.5% 
Other health problems Yes 11 11.0% 19 9.0% 30 9.7% 
No 89 89.0% 191 91.0% 280 90.3% 
 
Table (4.3) described the prevalence of some health problems among healthcare workers 
after their work either daytime or rotating shift and the medical history of their families.  
Diabetes mellitus was found in 12.6% of study population with higher percentage in 
daytime workers than rotating shift workers (17.0% vs. 10.5%, respectively). Among their 
family members (49.0% vs. 42.9%) respectively had diabetes. Regarding to HD, it was 
found in 3.9% of study population with higher percentage in daytime workers than rotating 
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shift workers (6.0% vs. 2.9%). Among their family members (23.0% vs. 23.8%) 
respectively suffered from HD, also 24.8 % of study population had elevated cholesterol 
with higher percentage in daytime workers than rotating shift workers (33.0% vs. 21.0%) 
respectively). Among their family members (19.0% vs. 26.7%) respectively had elevated 
cholesterol. More than third (35.5%) of the study population had high TG, where 41.0% 
from the daytime workers and 32.9% of the rotating shift workers. There were 18.0% of 
daytime family members had elevated TG, while 21.4% of rotating shift family members 
had elevated TG. HTN was found in 12.6% of study population with higher percentage in 
daytime workers than rotating shift workers (16.0% , 11.0%) respectively. Among their 
family members (53.0% vs. 52.9%) respectively had HTN . Chronic inflammation was 
found in 55.5% of healthcare workers with higher percentage in rotating shift than daytime 
workers (48.0% vs. 59.0%). 
4.1.4 Lifestyle of health personnel 
In this part we focused on four categories: cigarette smoking, body weight increasing 
(BMI> 25), use TV or computer for a long times, and exercise  especially walking 
Table (‎4.4): Distribution of the study population by their health behaviors (N= 310) 
Variable Category 
Current 
daytime  
workers 
Rotating shift 
workers 
Total 
(N=100, 
32.3%) 
(N=210, 
67.7%) 
(N=310, 
100%) 
N % N % N % 
Cigarette  smoking 
Yes 15 15.0% 49 23.3% 64 20.6% 
Stopped 9 9.0% 12 5.7% 21 6.8% 
No 76 76.0% 149 71.0% 225 72.6% 
Body weight status 
BMI> 25 
Yes 36 36.0% 104 49.8% 140 45.3% 
No 64 64.0% 105 50.2% 169 54.7% 
Use TV or 
computer for a 
long times 
Always 4 4.0% 14 6.7% 18 5.8% 
Sometimes 29 29.0% 38 18.2% 67 21.7% 
Rarely 35 35.0% 67 32.1% 102 33.0% 
No 32 32.0% 90 43.1% 122 39.5% 
Exercise  
especially walking 
Always 29 29.0% 63 30.0% 92 29.7% 
Sometimes 49 49.0% 90 42.9% 139 44.8% 
Rarely 12 12.0% 37 17.6% 49 15.8% 
No 10 10.0% 20 9.5% 30 9.7% 
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Table (4.4) described the lifestyle of health personnel of study population. According to 
our results only 20.6% of study population were smokers. About 45.3 % of the study 
population had increase in their weight (BMI > 25). Of these, 36.0% were in daytime 
workers which were lower than what we found in shift workers (49.8%). As shown in table 
(4.4), there were 43.1% of the rotating shift workers did not use TV or computer for a long 
times (more than 4 hours) during the shift, while 32.1% rarely use, 18.2% sometimes use 
and only 6.7% of them always uses TV. The percentage of day workers who using TV or 
computer for a long times was higher than the percentage of rotating shift workers. 
However, the prevalence of practice sport especially walking among rotating shift workers 
was higher than daytime workers. Table (4.4) 
4.2 Inferential statistics of self-administering questionnaire 
Table (‎4.5): Anthropometric and metabolic characteristics of study population (N= 310) 
 
* Significant at 0.05                    
 
 
Current daytime 
workers  
(N=100, 32.3%) 
Rotating shift 
workers 
 (N=210, 67.7%) t-test P-value 
Mean SD Mean SD 
Age 40.6 11.0 33.2 7.5 6.13 0.001* 
Body Mass Index 
(BMI) 
27.5 4.4 26.8 4.0 1.32 0.188 
Fasting blood 
sugar (FBS) 
101.6 41.7 94.1 29.6 1.63 0.105 
Triglyceride 
(TG) 
147.7 83.2 154.0 117.2 -0.48 0.629 
HDL-High 
density 
lipoprotein 
(HDL-C) 
48.7 3.7 49.5 2.5 -1.93 0.056 
C- Reactive 
Protein (CRP) 
6.4 5.2 5.8 5.1 0.92 0.358 
WBC 6.9 1.8 7.5 12.2 -0.436 0.663 
Lymphocyte 2.4 2.7 2.5 2.3 -0.550 0.583 
Granulocyte 3.9 1.5 3.7 1.3 1.219 0.224 
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Table (4.5) showed that the mean age of current daytime workers was 40.6 ± 11 years vs. 
33.2 ± 7.5 years among rotating shift workers and the difference was statistically 
significant (P value < 0.05). For BMI of current daytime and rotating shift workers, the 
mean was (27.5 ± 4.4 vs. 26.8 ± 4.0 respectively). For the FBS the mean was 101.6 ± 41.7 
vs. 94.1 ± 29.6, respectively and 147.7 ± 83.2 vs. 154.0 ± 117.2 for TG respectively .The 
mean of HDL-C was (48.7 ± 3.7 vs. 49.5 ± 2.5, respectively) while the mean of CRP  was 
(6.4 ± 5.2 vs. 5.8 ± 5.1, respectively). The mean of WBC and its differential counts 
(lymphocyte and granulocyte) among daytime and rotating shift workers was (6.9 ± 1.8 
vs.7.5 ± 12.2, 2.4 ± 2.7 vs. 2.5 ± 2.3, 3.9 ± 1.5 vs. 3.7 ± 1.3) respectively. For all metabolic 
and inflammatory risk factors, the difference was not statistically significant between 
daytime and rotating shift workers (P value < 0.05).  
our results were in contrast with a study done by Asare-Anane et al. (2015) in which the 
mean ages for the shift and the non-shift workers were 42.0 and 40.3 years respectively 
and  the difference in age between shift workers and non-shift workers was not statistically 
significant (p = 0.331), BMI of the shift working group was higher than that for the non-
shift working group (26.9 ± 4.6 vs 25.2 ± 3.3, respectively) and was statistically significant 
(p = 0.013). The mean FBS, serum TC, low density lipoproteins, TG and were significantly 
higher in shift workers compared to controls (p < 0.004) Also, the mean hs-CRP was 
significantly increased in the shift workers group compared to the non-shift workers (2.5 ± 
1.1 vs 1.8 ± 1.1, p < 0.0001).This may be due to healthy habits such as physical activity 
and dietary intake of  rotating shift workers. A study done by Ye et al. (2013) was 
inconsistent with our results that the age was statistical significant between the day work 
group and shift work group (p < 0.001), and HDL-C  was not statistically different between 
the two groups (P= 0.540). 
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Table (‎4.6): Relationship between the different risk factors and shift category among 
daytime and rotating shift healthcare workers (N=310) 
Risk factors Level 
Current 
daytime  
workers 
Rotating 
shift 
workers 
Total 
Chi- 
Square 
(x
2 
) 
OR 
95% 
CI 
P-
value 
(N=100, 
32.3%) 
(N=210, 
67.7%) 
(N=310, 
100%) 
N % N % N % 
BMI >30 (Obese) 
No 73 73.0% 173 82.4% 245 79.4% 
3.64 
0.6 0.3-1.0 0.056 
Yes 27 27.0% 37 17.6% 64 20.6% 0.7 0.4-1.2 0.172 
Blood pressure (BP) 
(mmHg) 
<130/85 
 
84 84.0% 187 89.0% 271 87.4% 
1.57 
0.7 0.3-1.3 0.210 
≥130/85 16 16.0% 23 11.0% 39 12.6% 1.6 0.8-3.1 0.210 
Fasting blood sugar 
(FBS) 
(mg/dl) 
<110 83 83.0% 188 89.5% 271 87.4% 
2.62 
1.8 0.9-3.5 0.105 
 
≥110 
 
17 17.0% 22 10.5% 39 12.6% 0.6 0.3-1.1 0.105 
T. Cholesterol 
(TC) 
(mg/dl) 
< 200 67 67.0% 166 79.0% 233 75.2% 
5.27 
0.5 0.3-0.9 0.022* 
≥200 33 33.0% 44 21.0% 77 24.8% 1.9 1.1-3.2 0.022* 
Triglyceride (TG) 
(mg/dl) 
Normal 59 59.0% 141 67.1% 200 64.5% 
1.96 
0.7 0.4-1.2 0.161 
Abnormal 41 41.0% 69 32.9% 110 35.5% 1.4 0.9-2.3 0.161 
High density 
lipoprotein 
(HDL-C) 
(mg/dl) 
Normal 82 82.0% 193 91.9% 275 88.7% 
6.64 
0.4 0.2-0.8 0.010* 
Abnormal 
(decreased) 
18 18.0% 17 8.1% 35 11.3% 2.5 1.2-5.1 0.010* 
low density 
lipoprotein 
(LDL-C) 
(mg/dl) 
Normal 70 70.0% 182 86.7% 252 81.3% 
12.37 
0.4 0.2-0.6 0.001* 
Abnormal 
(increased) 
30 30.0% 28 13.3% 58 18.7% 2.8 1.6-5.0 0.001* 
C- Reactive Protein 
(CRP) 
Normal 48 48.0% 124 59.0% 172 55.5% 
3.35 
0.6 0.4-1.0 0.067 
Abnormal 52 52.0% 86 41.0% 138 44.5% 1.6 1.0-2.5 0.067 
Leukocyte count 
Normal 51 100.0% 249 96.1% 300 96.8% 
0.99 
- - 
0.321 
Increased 0 0.0% 10 3.9% 10 3.2% - - 
Neutrophil count 
Normal 50 98.0% 253 97.7% 303 97.7% 
0.13 
- - 0.719 
Increased 1 2.0% 6 2.3% 7 2.3% - - 
Lymphocyte count 
 
Decreased 0 0.0% 1 %0.4  1 0.3% 
0.82 
- - 
0.365 
Normal 51 100.0% 258 %99.6  309 99.7% - - 
Metabolic syndrome 
Absent 91 91.0% 193 91.9% 284 91.6% 
0.07 
0.9 0.4-2.1 0.788 
Present 9 9.0% 17 8.1% 26 8.4% 1.1 0.5-2.6 0.788 
* Significant at 0.05                       
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Our findings demonstrated that 8.4% of health personnel had MetS with higher prevalence 
among day worker 9.0% than rotating shift workers 8.1% ,with  no statistical relationship 
(x2= 0.07, P-value>0.05) between MetS and shift category, which mean that daytime and 
rotating shift workers had the same opportunity to have MetS.  
The most common abnormalities among study population in our study were as follow: 
elevated CRP, high level of TG, elevated level of TC, increased BMI >30, high level of 
LDL-C, increased FBS and BP, and low HDL-C, increased WBC count, increased 
neutrophil count, and decreased lymphocyte count with 44.5%, 35.5%, 24.8%, 20.6%, 
18.7%, 12.6%, and 11.3%, 3.2%, 2.3%, 0.3% respectively. This study was the first that 
explored the prevalence and the effect of rotating shift on biomarkers of MetS and 
inflammation among health personnel in the Mediterranean countries. 
The relationship between shift category and the related risk factors were studied. Table 
(4.6) showed that 27.0% of daytime workers were obese (BMI > 30) vs. 17.6% of rotating 
shift workers, without statistical relationship (x2= 3.64, P-value> 0.05). For FBS, 17.0% of 
the daytime workers had elevated FBS vs. 10.5% in rotating shift workers with no 
statistical relationship (x2= 2.62, P-value>0.05). Also16.0% of the daytime workers had 
elevated BP vs. 11.0% of rotating shift workers without statistical relationship (x2= 1.57, P-
value > 0.05). 
Also the study revealed that 33.0% of the daytime workers had elevated cholesterol, while 
21.0% from the rotating shift workers had elevated cholesterol, with statistically significant 
difference, (OR=1.9, 95% CI= 1.1-3.2). For TG, 41.0% of the daytime workers had 
elevated TG vs. 32.9% of the rotating shift workers with no statistical relationship (x2= 
1.96, P-value>0.05). As well as 18.0% of the daytime workers had low level of HDL vs. 
8.1% of rotating shift workers, and the difference was statistically significance (P = 0.010). 
About 30.0% of daytime workers had high LDL while 13.3% of the rotating shift workers 
had elevated LDL with statistical relationship, (OR= 2.8, 95% CI=1.6-5.0). Finally 52.0% 
of  daytime workers had elevated CRP vs. 41.0% of rotating shift workers without 
statistical relationship (P-value>0.05). Moreover, there were no statistical differences in 
the CBC results including WBC and its differential counts between daytime and rotating 
shift workers.  
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Our results showed that the obesity in daytime workers was higher than in current shift 
workers. Our findings were consistent with a study that conducted in Korea on 9,989 
female nurses, in which obesity for shift workers and non-shift workers were 5.8% and 9.1 
respectively (Rhee et al., 2013). But it was not consistent with a cross-sectional study from 
Australia in which nurses who had shift work were 1.15 times more likely to be overweight 
or obese than day workers (Zhao et al., 2011). BMI in daytime workers was higher than 
that in shift workers, which might be influenced by relatively older age of daytime 
workers, as well as other potential confounding factors.  
Regarding to elevate BP, our findings were in accordance with cross-sectional survey of a 
representative sample of 493 nursing staff of a large general hospital in (Hospital São 
Vicente de Paulo). Passo Fundo, Brazil. Their results showed that17.7% of the day workers 
had HTN, while 13.9 and 17% of morning and evening night shift workers had HTN 
respectively. Their findings indicated that there was no association between shift work and 
HTN. Another study performed in Iran by Mohebbi et al. (2012) showed a similar results 
in which 37.4% of day workers had elevated systolic BP > 130 or diastolic BP > 85 
mmHg, while 35.8% of shift workers had elevated systolic BP > 130 or diastolic BP > 85 
mmHg, with no statistically difference between the two groups (P = 0.101, OR= 0.933, 
95% CI =0.840–1.036), so the HTN component was not significantly related to shift work 
(p > 0.05).  
Some studies identified a trend towards higher BP among shift workers. Ye et al. (2013) 
showed that shift worker had elevated HTN than day workers (50.3%, 28.2 %) 
respectively. The researcher clarified this by the old age. 32.2% of shift workers in this 
study were above 50 years and only 11.3% of day workers were above 50 years. 
Regarding fasting glucose, we found the most altered values among day workers, this 
frequency of altered fasting glucose levels were expected because 88.2% of day workers 
were above 40 years had elevated FBS, while 45.5% of rotating shift workers were above 
40 years had elevated FBS, and the fact that increased levels of blood glucose are 
associated with increasing age (Kawada et al., 2010; Sumner et al., 2012). Similar results 
were found in a study performed in Brazil by Canuto, R. et al. (2015) in which their results 
revealed that elevated FBS was more in day workers than night shift workers (4.9% ,  
3.8%) respectively. However, a study by Ye et al. (2013) found that FBS was more among 
shift workers (24.6%) than day workers (4.2%) (P < 0.001). This can be explained by that 
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most shift workers were aged between 40-49 years (55%) while most day workers were 
aged between 18-39 years (64.8%). 
Our results showed a significant difference in cholesterol, HDL-C, and LDL-C between 
shift workers and day workers on the first observation where day workers had increased 
results (P <0.05), but no such difference was observed for TG (P > 0.05). A study that 
conducted by Nazri, et al. (2007) for estimation of HDL- C in day and shift workers 
showed a consistent result that the day workers had hypo- HDL-C more than shift workers 
(13.89%, 9.21% respectively). Meanwhile, their result showed no statistically difference 
relationship between the two groups, our findings were in contrast where we found a 
significant different between HDL-C level of daytime and shift workers. 
In this study the result of HDL-C was statistically significant between the two groups refer 
to that most daytime workers were older and traditionally HDL levels below the reference 
value have been associated with increasing age, especially among women (Bello & Mosca, 
2004). 
The result regarding TG that obtained in this study was similar to a cross sectional study on 
12 shift workers and 13 day workers using pre and post test, during a six-month period, 
that demonstrated the prevalence of TG among day workers and shift workers was (28%, 
25% respectively) with no significant difference between the two groups (P>0.05) 
(Knutson et al., 1990). In addition, another study on 58 nurses (30 shift workers and 28 day 
workers), during a period of 18 months, demonstrated that there was no correlation 
between TG and shift work between the two groups (Copertaro et al., 2008). However, a 
study conducted by Sookoian et al. (2007) demonstrated that the mean of TG among shift 
and day workers was (1.7 ± 0.1, 1.5 ± 0.1 respectively) with statistically difference 
between the two groups (P=0.003). The researcher explained their results that rotating shift 
workers may do more exercise and more active than day workers because they were 
younger while the daytime workers were older and less active. Exercise is known to reduce 
overall metabolic risk factors, improving lipid metabolism and lowering BP (Jennings et 
al., 1986; Pan et al., 1997). 
According to Sookoian et al. leukocyte count was significantly higher in shift workers than 
in daytime workers (6530 ± 1,216 , 5556 ± 1,123,  cells/μL, respectively, P= <0.001), 
Puttonen et al. also reported an increase in hs-CRP in 3-shift workers and an increase in 
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leukocyte count in 2-shift and 3-shift workers, additionally a study done by Lu et al. 
showed that increased total and differential leukocyte counts (neutrophil, monocyte, and 
lymphocyte) were associated with shift work (P < 0.05), thus disagreeing with our 
findings. The researcher explained that may be due to the type of job and the age that most 
day workers were above 40 years and CRP level affected by age.  
Our results for this study showed that according to NCEP-ATP Ш criteria, the prevalence 
of MetS among health personnel who work at ASH and ANPH in Gaza was 8.4% and the 
prevalence increases as age increases. Studies in Parkistan (Alam et al., 2011) and 
Lampang hospital (Phengtham, 2011) revealed higher rates of 14.95 and 9.5%, 
respectively than the prevalence of this study. In another study conducted in Ethiopia (Tran 
et al., 2011), using the NCEP-ATP III, the overall prevalence of MetS was 12.5 which is 
higher than our prevalence (8.4%) in this study. 
In this study the researcher observed that there were no statistical differences between 
rotating shift work and the MetS when compared with current day workers. This finding of 
no association between shift work and MetS we found was consistent with a study 
performed on male workers with rotating three shift works (Karlsson et al., 2003), and a 
study done by Shafei et al. (2011) where both studies showed that shift work was not 
significantly associated with MetS. This could be explained by the positive values that the 
healthcare workers had such as more exercise, walking during the shift and outside the 
work as well as fast forward rotation shift schedule practice among rotating shift workers. 
Fast forward rotation is at this time considered the best in reducing sleep loss and fatigue 
among shift workers (Katriina et al., 2008), thus reducing other health effects linked with 
circadian rhythm disruption, also daytime workers were not only involved with their job 
some of them had administrative job that increased the stress that may involve in the 
mechanism of MetS. In addition, environmental and genetic factors had been implicated in 
the development of this syndrome. Older age, sedentary lifestyle, and high-fat diet can 
increase the prevalence of MetS (Brage et al., 2004).  
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Table (‎4.7): Prevalence of metabolic syndrome by gender and work category (N=310) 
Work  
Category 
Variable Category 
Metabolic Syndrome 
OR 
95% 
CI 
P- 
value 
Present Absent Total 
N % N % N % 
Daytime  
workers 
Gender 
Male 5 55.6% 51 56.0% 56 56.0% 1.0 
0.2-
3.9 
0.978 
Female 4 44.4% 40 44.0% 44 44.0% 1.0 
0.3-
4.1 
0.978 
Total 9 9.0% 91 91.0% 100 100.0% 
(Fisher-exact  
x
2
=0.10, 
 p-value=0.746) 
Rotating 
 shift 
 workers 
Male 14 82.4% 142 73.6% 156 74.3% 1.7 
0.5-
6.1 
0.427 
Female 3 17.6% 51 26.4% 54 25.7% 0.6 
0.2-
2.2 
0.427 
Total 17 8.1% 193 91.9% 210 100.0% 
(Fisher-exact  
x
2
=0.25,  
p-value=0.614) 
 * Significant at 0.05                      
                 
Most of the medical staff from both groups who had MetS were males with percent equal 
(55.6% daytime vs. 82.4% rotating shift), while the remaining were females (44.4% 
daytime vs. 17.6% rotating shift), without major statistical significant relationship (p-
value> 0.05) between MetS and gender among both groups of medical staff at ASH and 
ANPH in the Gaza Strip (daytime, rotating shift), which mean that medical staff males and 
females had the same opportunity to have MetS.  
According to our results, the prevalence of MetS was higher in males than females among 
both work category, which come in steady with study conducted by Cheserek et al. (2014) 
in which the prevalence was greater in 40-49 years age group among males (25.2%) than 
among females (16.6%) and the overall MetS prevalence was 6.1%, and was higher in 
males (5.1%) than females (1.1%). Another study by Sirdah et al. (2012) showed that there 
were no significant differences in the prevalence of MetS between males and females 
whether applying the NCEP/ATP III or IDF definition (P> 0.05). In a Dutch population, 
the prevalence of MetS was higher in men 26.7% than in women 22.8% (P= 0.02) by ATP 
III criteria (Cordero et al., 2006). In contrast, among Qatari population, the prevalence of 
MetS was significantly higher in women by ATP III (61.4% vs. 38.6%, P <0.001). Also,  
in the United Kingdom, the MetS was significantly more frequent in females (24.9% vs. 
17.4%, P <0.001).  
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Table (‎4.8): CRP level according to gender and work category (N=310) 
Work  
category 
Variable Category 
CRP (mg/L) 
OR 
95% 
CI 
P- 
value 
Elevated Normal Total 
N % N % N % 
Daytime  
workers 
Gender 
Male 28 53.8% 28 58.3% 56 56.0% 0.8 
0.4-
1.8 
0.652 
Female 24 46.2% 20 41.7% 44 44.0% 1.2 
0.5-
2.6 
0.652 
Total 52 52.0% 48 48.0% 100 100.0% 
(x
2
=0.20, 
 p-value= 0.401) 
Rotating 
shift 
workers 
Male 65 75.6% 91 73.4% 156 74.3% 1.1 
0.6-
2.1 
0.721 
Female 21 24.4% 33 26.6% 54 25.7% 
0.9 0.5-
1.7 
0.721 
Total 86 41.0% 124 59.0% 210 100.0% 
(x
2
=0.13,  
p-value= 0.751) 
* Significant at 0.05                      
Table (4.8) showed that 52.0% of day workers had elevated level of CRP with higher 
percentage in males 53.8% than females 46.2%. Also, 41.0% of rotating shift workers had 
high level of CRP with higher in males 75.6% than females 24.4% without statistically 
significant difference (p-value> 0.05) between level of CRP and gender among both 
groups. 
To date, relatively slight had been written regarding the comparison of gender differences 
in CRP concentrations among East Asians. Our results supported by Yamada et al. study 
that performed in a Jichi Medical School, in Japan. The study sample was consisted of 
2275 men and 3832 women. The men showed elevated CRP concentrations in comparison 
to women. Our findings were in agreement with this aforementioned study where men 
showed higher CRP concentrations compared with women. Controversially, an 
observational study of Chinese subjects showed no difference in CRP concentrations with 
respect to gender (Ye et al., 2007).  
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Table (‎4.9): Prevalence of MetS by age and work category (N=310) 
Work 
 category 
varia
ble 
Category 
Metabolic syndrome 
OR 95% CI 
P- 
value Present Absent Total 
N % N % N % 
Daytime 
workers 
Age 
30 years 
& less 
0 0.0% 17 18.7% 17 17.0% - - - 
31-40 
years 
3 33.3% 28 30.8% 31 31.0% 1.1 0.3-4.8 0.874 
41 years 
& above 
6 66.7% 46 50.5% 52 52.0% 2.0 0.5-8.3 0.356 
Total 9 9.0% 91 91.0% 100 100.0% 
(Fisher-exact x
2
=1.78, p-
value=0.512) 
Rotating 
shift 
workers 
Age 
31 years 
& less 
1 5.9% 98 50.8% 99 47.1% 0.1 0-0.5 0.001* 
31-40 
years 
8 47.1% 60 31.1% 68 32.4% 2.4 0.8-62 0.117 
41 years 
& above 
8 47.1% 35 18.1% 43 20.5% 4.5 1.6-12.9 0.002* 
Total 17 8.1% 193 91.9% 210 100.0% 
(Fisher-exact x
2
=15.53, 
p-value=0.001*) 
* Significant at 0.05                      
According to our results, in the daytime workers and shift workers, respectively, MetS 
increased from 0% and 5.9% within less than 30 year-old group to 66.7% and 47.1% in the 
participants of more than 41 years of age. There was a statistical significant relationship (p-
value<0.05) between MetS and age (30 years & less, 31- 40 years, 41 years & above) 
among rotating shift workers. In addition, for rotating shift workers the result showed that 
the ratio of having MetS for 41 years and above equals 4.5 times of other age groups and 
their percent of susceptible ranging between 1.6 to 12.9 times. Our result regarding age and 
MetS among rotating shift workers come in agreement with two previous studies on shift 
workers where both studies also reported that age was directly associated with MetS 
(Moreira et al., 1996; Esquirol et al., 2009; Kaduka et al., 2012). 
The prevalence rate of the MetS in South Korean adults increases with age (Korean centers 
for disease control and prevention, 2007). Our findings were in agreement with another 
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study that done by Hui Ye et al. (2013) which showed that for the age brackets of under 40, 
40–49 years old, and 50 and above, BP was 26.5%, 44.5%, and 61.2%, respectively; 
fasting blood glucose was 7.4%, 16.0%, and 35.8%; WC was 7.4%, 5.0%, and 9.0%; TG 
levels were 10.3%, 13.4%, and 29.9%; low high-density lipoprotein cholesterolemia was 
22.1%, 21.0%, and 40.3%; and the prevalence of the MetS was 7.4%, 7.6%, and 23.9%, 
respectively. These results showed signs of an increase in the prevalence of the MetS and 
abnormalities of each MetS component as the age brackets increased (Ye et al., 2013).  
Table (‎4.10): Prevalence of MetS according to job and work category (N=310) 
Work 
category 
variable Category 
Metabolic syndrome 
OR 
95% 
CI 
P- 
val
ue 
Present Absent Total 
N % N % N % 
Daytime 
workers 
Job 
Physicians 2 22.2% 29 31.9% 31 31.0% 0.6 
0.1-
3.1 
0.5
50 
Practical 
nursing 
5 55.6% 46 50.5% 51 51.0% 1.2 
0.3-
4.8 
0.7
74 
Radiologists, 
radiologic 
technologists, 
and  medical 
technologists 
2 22.2% 16 17.6% 18 18.0% 1.3 
0.3-
7.1 
0.7
30 
Total 9 9.0% 91 91.0% 100 
100.0
% 
(Fisher-exact 
x
2
=0.54, p 
value=0.810) 
Rotating 
shift 
workers 
Job 
Physicians 12 70.6% 79 40.9% 91 43.3% 3.5 
1.2-
10.2 
0.0
18* 
Practical 
nursing 
5 29.4% 100 51.8% 105 50.0% 0.4 
0.1-
1.1 
0.0
77 
Radiologists, 
radiologic 
technologists, 
and  medical 
technologists 
0 0.0% 14 7.3% 14 6.7% - - - 
Total 17 8.1% 193 91.9% 210 
100.0
% 
(Fisher-exact 
x
2
=4.98, p value= 
0.076) 
* Significant at 0.05                      
According to our results regarding daytime workers, the most prevalent of MetS was found 
among practical nursing (55.6%), and the difference did not reach the statistical 
significance (P=0.774), while among rotating shift workers the most prevalent of MetS 
was found among physicians with 70.6% and the difference reached a statistical significant 
difference in comparison to other jobs (P-value= 0.018) table 4.10. Yet, this was the first 
study that performed among healthcare workers in Gaza strip, and most studies that we 
found in the literature were performed only among nurses (Pietroiusti et al., 2010;   Ahmad 
et al., 2011). 
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Table (‎4.11): Relationship between metabolic syndrome and previously exposed night 
shifts among both groups (N=310) 
Work 
category 
Variable Category 
Metabolic syndrome 
OR 
95% 
CI 
P- 
value 
Present Absent Total 
N % N % N % 
Daytime 
 workers 
Years 
not 
exposed 
1 11.1% 16 17.6% 17 17.0% 0.6 0.1-5.0 0.622 
1-5 years 2 22.2% 19 20.9% 21 21.0% 1.1 0.2-5.6 0.925 
more 
than 5 
years 
6 66.7% 56 61.5% 62 62.0% 1.3 0.3-5.3 0.762 
Total 9 100.0% 91 100.0% 100 100.0% 
(Fisher-exact 
 x
2
=0.25, 
 p-value=0.999) 
Rotating  
shift  
workers 
Years 
not 
exposed 
0 0.0% 5 2.6% 5 2.4% - - - 
1-5 years 3 17.6% 83 43.0% 86 41.0% 0.3 0.1-1.0 0.042* 
more 
than 5 
years 
14 82.4% 105 54.4% 119 56.7% 3.9 1.1-14.0 0.026* 
Total 17 100.0% 193 100.0% 210 100.0% 
((Fisher-exact  
x
2
=4.57,  
p-value=0.099) 
   * Significant at 0.05                       
Table (4.11) showed that 66.7% of the daytime workers who have MetS had been exposed 
to night shifts previously for more than 5 years without statistical significant relationship 
vs. 82.4% in the rotating shift workers with statistical significant relationship (P-value= 
0.026 OR= 3.9, 95% CI= 1.1-14), this mean that rotating shift workers who have night 
shifts more than 5 years have four times to have MetS than workers who had night shifts 
less than 5 years, while 22.2% of daytime workers who have MetS had been exposed to 
night shifts previously from one year to five years without statistical relationship vs. 17.6% 
in the rotating shift workers and the difference was statistical significance (P- value= 
0.042) between MetS and the exposed night shifts among rotating shift workers. Our 
results come in consistent with a study done by Guo et al. which suggested that the ORs for 
MetS increased with the extension of shift work duration. Every 10 years increase of shift 
work was related to 17% increase of OR in the unadjusted model (Guo et al., 2015). Also, 
another study that conducted by Shafei et al. (2011) supported our results and showed that 
nurses who worked 10 years more than others were two times more likely to have MetS. 
Moreover, another study in Turkey found that MetS was significantly higher among 
workers who had been working for more than 10 years (Demiral et al., 2006). This result 
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implies that nurses who had longer duration of employment were more senior and they had 
a longer duration of exposure to physical inactivity, thus increased their risk towards MetS. 
Table (‎4.12): Relationship between elevated CRP and previously exposed night shifts 
among day and shift workers (N=310) 
Work 
 
category 
Variable Category 
CRP 
OR 
95% 
CI 
P- 
value 
Elevated Normal Total 
N % N % N % 
Daytime 
 workers 
Years 
not 
exposed 
5 9.6% 12 25.0% 17 17.0% 0.3 0.1-1.0 0.040* 
1-5 years 8 15.4% 13 27.1% 21 21.0% 0.5 0.2-1.3 0.151 
more than 
5 years 
39 75.0% 23 47.9% 62 62.0% 3.26 1.4-7.6 0.005* 
Total 52 100.0% 48 100.0% 100 100.0% 
(Fisher-exact 
x
2
=7.95,p-
value=0.018*) 
Rotating  
shift 
 workers 
Years 
not 
exposed 
1 1.2% 4 3.2% 5 2.4% 0.4 0-3.2 0.335 
1-5 years 34 39.5% 52 41.9% 86 41.0% 0.9 0.5-1.6 0.728 
more than 
5 years 
51 59.3% 68 54.8% 119 56.7% 1.2 0.7-2.1 0.572 
Total 86 100.0% 124 100.0% 210 100.0% 
(Fisher-exact 
x
2
=1.01,p-
value=0.598) 
* Significant at 0.05                      
According to the results presented in table (4.12), most of daytime and rotating shift 
workers who have elevated CRP had been exposed to night shifts for more than 5 years 
(75.0%, and 59.3%) respectively, with statistically significant relationship among day 
workers (OR=3.26, 95% CI =1.4-7.6), but the differences did not reach the statistical 
significance among rotating shift workers (P =0.572), this may related to their ages (mean 
of their age was 33.2) and we know that CRP affected by age after 40 years. 
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Table (‎4.13): The prevalence of metabolic syndrome by currently exposed night shifts per 
month (N=210) 
Work 
category 
Category 
Metabolic syndrome 
OR 95% CI P- value Present Absent Total 
N % N % N % 
Rotating 
shift 
workers 
not exposed 2 11.8% 9 4.7% 11 5.2% 2.7 0.5-13.8 0.208 
1-5 night 
shifts 
4 23.5% 56 29.0% 60 28.6% 0.8 0.2-2.4 0.631 
more than 5 
night shifts 
11 64.7% 128 66.3% 139 66.2% 0.9 0.3-2.6 0.892 
Total 17 100.0% 193 100.0% 210 100.0% 
(Fisher-exact x
2
=1.95, p-
value=0.345) 
* Significant at 0.05  
The highest prevalence of MetS was found in workers who have more than five nightshifts 
monthly with percent 64.7%, and the lowest prevalence was among those who not exposed 
to night shifts with percent 11.8%. There was no statistically significant relationship (p-
value>0.05) between MetS and currently exposed night shift per month table (4.13). 
Table (‎4.14): The prevalence of CRP level by currently exposed night shifts per month 
(N=210) 
Work 
category 
Category 
CRP 
O
R 
95% CI 
P- 
value 
Elevated Normal Total 
N % N % N % 
Rotating 
shift 
workers 
not exposed 3 3.5% 8 6.5% 11 5.2% 0.5 0.1-2.0 0.343 
1-5 night 
shifts 
58 67.4% 81 65.3% 139 66.2% 1.1 0.6-2.0 0.750 
more than 5 
night shifts 
25 29.1% 35 28.2% 60 28.6% 1.0 0.6-1.9 0.894 
Total 86 100.0% 124 100.0% 210 100.0% 
(Fisher-exact X
2
=0.83,p-
value=0.735) 
* Significant at 0.05                      
Table (4.14) showed that 29.1% of the night shift workers who have elevated CRP had 
night shifts duties more than 5 night shifts monthly, 67.4% who have from one to five 
night shifts monthly had elevated CRP, and 3.5% among of them not exposed to night shift 
had elevated CRP. And the difference didn‘t show statistical significance (P> 0.05). 
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Table  (‎4.15): Prevalence of different factors that define metabolic syndrome (According 
to ATPШ definition) and inflammation among current daytime workers (N= 100) 
Components 
of MetS 
Level 
Metabolic syndrome 
OR 95% CI P- value Present Absent Total 
N MetS% N % N % 
FBS 
(mg/dl) 
≥110 5 55.6% 12 13.2% 17 17.0% 8.2 1.9-35.0 0.001* 
<110 4 44.4% 79 86.8% 83 83.0% 0.1 0-0.5 0.001* 
BP 
(mmHg) 
≥130/85 6 66.7% 10 11.0% 16 16.0% 16.2 3.5-75.1 0.001* 
<130/85 3 33.3% 81 89.0% 84 84.0% 0.1 0-0.3 0.001* 
Obesity 
(BMI > 30) 
Yes 6 66.7% 21 23.1% 27 27.0% 6.7 1.5-29.0 0.005* 
No 3 33.3% 70 76.9% 73 73.0% 0.2 0-0.7 0.005* 
TG (mg/dl) 
≥150 8 88.9% 33 36.3% 41 41.0% 
14.1 1.7-117.4 0.002* 
<150 1 11.1% 58 63.7% 59 59.0% 
0.1 0-0.6 0.002* 
HDL-C 
(mg/dl) 
<50 for 
women 
< 40 for 
men 
(Abnormal) 
4 44.4% 14 15.4% 18 18.0% 4.4 1.1-18.4 0.030* 
> 50 for 
women 
> 40 for 
men 
(Normal ) 
5 55.6% 77 84.6% 82 82.0% 0.2 0.1-1.0 0.030* 
CRP 
(mg/L) 
Abnormal 4 44.4% 48 52.7% 52 52.0% 0.7 0.2-2.8 0.634 
Normal 5 55.6% 43 47.3% 48 48.0% 1.4 0.4-5.5 0.634 
* Significant at 0.05     
From table (4.15) the researcher computed the odds ratio and the confidence interval of 
daytime workers with MetS, by comparing the measurement of each component of the 
MetS for the normal and the abnormal level. In our study, 55.6% of participants with high-
level of FBS had MetS vs. 44.4% with normal FBS, this difference was statistically 
significant (OR = 8.2, 95% CI =1.9-35.0). For Bp, 66.7% of daytime workers who had 
high Bp had MetS vs. 33.3% with normal Bp and the difference was statistically 
significant, (OR= 16.2, 95% CI = 3.5-75.1).  
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Moreover, 66.7% of daytime workers with BMI>30 had MetS vs. 33.3% with BMI <30 
and the difference was statistically significant OR 6.7 CI 95% (1.5-29.0), then the study 
showed that 88.9% of daytime workers with high TG had MetS vs. 11.1% with normal 
level of TG OR (95% CI) 14.1 (1.7-117.4). Additionally, 44.4% with low level of HDL 
cholesterol had MetS vs. 55.6% with normal level, and the difference reached a statistical 
significant level (P= 0.030). Finally 44.4% of participant with elevated CRP had MetS vs. 
55.6% with normal level but the difference didn‘t reach the statistical significant level  
(P= 0.634).  
We concluded that the risk factors of MetS among daytime workers based on value of OR 
in our sample is in descending order were as follow: high BP, high level of TG , high FBS, 
elevated BMI >30, and low HDL cholesterol level. 
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Table (‎4.16): Prevalence of different factors that define metabolic syndrome (According to 
ATPШ definition) and inflammation among rotating shift workers (N=210) 
Components 
of MetS 
Level 
Metabolic syndrome 
OR 95% CI P- value Present Absent Total 
N MetS % N MetS% N % 
FBS (mg/dl) 
≥110 12 70.6% 10 5.2% 22 10.5% 43.9 12.9-149.1 0.001* 
<110 5 29.4% 183 94.8% 188 89.5% 0.02 0-0.1 0.001* 
BP 
(mmHg) 
 
 
≥130/85 13 76.5% 10 5.2% 23 11.0% 59.5 16.4-215.8 0.001* 
<130/85 4 23.5% 183 94.8% 187 89.0% 0.01 0-0.1 0.001* 
Obesity 
(BMI >30) 
Yes 11 64.7% 26 13.5% 37 17.6% 11.8 4.0-34.6 0.001* 
No 6 35.3% 167 86.5% 173 82.4% 0.1 0-0.3 0.001* 
TG 
(mg/dl) 
≥ 150 16 94.1% 53 27.5% 69 32.9% 42.3 5.5-326.6 0.001* 
<150 1 5.9% 140 72.5% 141 67.1% 0.02 0-0.2 0.001* 
HDL-C 
(mg/dl) 
<50 for 
women 
< 40 for 
men 
(Abnormal) 
2 11.8% 15 7.8% 17 8.1% 1.6 0.3-6.1 0.562 
> 50 for 
women 
> 40 for 
men 
(Normal) 
15 88.2% 178 92.2% 193 91.9% 0.6 0.1-3.0 0.562 
CRP (mg/L) 
Abnormal 10 58.8% 76 39.4% 86 41.0% 2.2 0.8-6.0 0.118 
Normal 7 41.2% 117 60.6% 124 59.0% 0.5 0.2-1.2 0.118 
* Significant at 0.05                      
The researcher computed the odds ratio and the confidence interval of rotating shift 
workers with MetS, by comparing the measurement of each component of the MetS for the 
normal and the abnormal level table (4.16). In our study 70.6% of participants with high-
level of FBS had MetS vs. 29.4% with normal FBS. This difference was found to be 
statistically significant, (P= 0.001, OR = 43.9, 95% CI= 12.9-149.1). For Bp, 76.5% of 
rotating shift workers who had high Bp had MetS vs. 23.5% with normal Bp had MetS. 
The difference was statistically significant, (P= 0.001, OR=59.5, 95% CI=16.4-215.8). 
Also, 64.7% of shift workers with BMI>30 had MetS vs. 35.3% with BMI<30 and the 
difference was statistically significant (P= 0.001, OR= 11.8, 95% CI= 4.0-34.6). Then the 
study showed that 94.1% of shift workers with high TG had MetS vs. only 5.9% with 
normal level of TG had MetS. Again these differences were statistically significant where 
(P= 0.001, OR= 42.3, 95% CI=5.5-326.6). Moreover, 11.8% of rotating shift workers with 
low level of HDL cholesterol had MetS vs. 88.2% with normal level, and the difference 
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didn‘t reach a statistical significant level. Finally, 58.8% of participant with elevated CRP 
had MetS vs. 41.2% with normal level but the difference didn‘t reach the statistical 
significant level (P= 0.118). 
We concluded that the risk factors of MetS among rotating shift workers based on value of 
OR in our sample is in descending order were as follow: high BP, high FBS, high level of 
TG , elevated BMI >30, and low HDL cholesterol level. They were in the order of risk 
factors in daytime workers except for FBS and TG (Table 4.15& 4.16). 
This was the first study that showed the prevalence of MetS and its related risk factors 
among daytime and rotating shift workers. Nevertheless, a study that conducted by Jamee 
et al. (2012) explore risk factors of MetS in cardiology clinic in Gaza strip- based on value 
of OR which come in descending order as follow: high FBS (OR12.9), Large WC (OR 
11.6), high BP (OR 8.3), high level of TG (OR 8.3), and low HDL cholesterol level (OR 
1.3).While in our study the risk factors among daytime workers were: high BP, high level 
of TG , high FBS, elevated BMI >30, and low HDL cholesterol level. Among rotating shift 
workers the risk factors were: high BP, high FBS, high level of TG, elevated BMI >30, and 
low HDL cholesterol level. 
From the results we concluded that increased BP was the main risk factor and this require 
regular check-up of BP in healthcare workers in order to identify individuals who have a 
higher risk of developing CVD and MetS. 
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5 Chapter (5) 
Conclusion and Recommendation 
This chapter provides the main conclusions of this study as well as recommendations for 
decision makers that could help to prevent and reduce the risk factors of MetS among 
health care workers (daytime and rotating shift).     
5.1 Conclusions 
This cross sectional study was carried out to explore the prevalence and effect of rotating 
shift work on biomarkers of metabolic syndrome and inflammation among health care 
personnel in Gaza governorates to raise recommendations that could be helpful for 
decision makers to improve gaps if found.  
An important finding of this study was the overall prevalence of MetS among health 
personnel was 8.4% (9% among daytime workers was which was higher than among 
rotating shift workers 8.1%) without statistical significant difference between the two 
groups, and the prevalence increases as age increases.  
According to the results of the study, MetS was more prevalent among male daytime and 
rotating shift workers than females. From the study finding the main common 
abnormalities among study population were as follow: elevated CRP, high level of TG, 
elevated level of cholesterol, increased BMI >30, high level of LDL-C, increased FBS, BP, 
and  low HDL-C with 44.5%, 35.5%, 24.8%, 20.6%, 18.7%, 12.6%, and 11.3% 
respectively. 
There were 27.0% of daytime workers obese (BMI > 30) vs. 17.6% of rotating shift 
workers, without statistical relationship (x2 = 3.64, P-value>0.05). For FBS, 17.0% of the 
daytime workers had elevated FBS vs. 10.5% in rotating shift workers with no statistical 
relationship (x2 = 2.62, P-value>0.05), also 16.0% of the daytime workers had elevated BP 
vs. 11.0% of rotating shift workers without statistical relationship (x2 = 1.57, P-value 
>0.05). 
A statistically significant difference (P- value= 0.022) appeared between cholesterol level 
and shift category with higher prevalence among daytime workers. For TG, 41.0% of the 
daytime workers had elevated TG vs.32.9% of the rotating shift workers with no statistical 
relationship (x2 = 1.96, P-value>0.05). The researcher observed differences between  low 
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level of HDL and high level of LDL and the shift category (P value = 0.01, 0.001 
respectively). From our results, there were no statistical differences in the CBC results 
including WBC and its differential count, and the level of CRP between daytime and 
rotating shift workers (P-value>0.05).There were 52.0% of daytime workers had elevated 
level of CRP with higher percentage in males 53.8% than females 46.2%. Also, 41.0% of 
rotating shift workers had high level of CRP with higher in males 75.6% than females 
24.4%. 
According to job among daytime workers, the highest prevalence of MetS was found among 
practical nursing (55.6%), while among rotating shift workers, the highest prevalence of 
MetS was found among physicians (70.6%). About 82.4% of rotating shift workers who 
have MetS had been exposed previously to night shifts for more than 5 years (P-value= 
0.026). Our results showed that most of daytime and rotating shift workers who had elevated 
CRP had been exposed to night shifts for more than 5 years (75.0%, and 59.3%) respectively 
and MetS was found in 64.7% of workers who have more than five shifts monthly, 23.5% 
among workers who have one to five night shifts, and11.8% among workers who haven‘t 
exposed to night shifts (only morning and evening). 
The current study also investigates the risk factors that define MetS among currently 
daytime workers which based on value of OR in descending order were as follow: high BP, 
high level of TG, high FBS, elevated BMI >30, and low HDL cholesterol level, while the 
risk factors  that define MetS among rotating shift workers which based on value of OR in 
descending order were as follow: high BP, high FBS, high level of TG, elevated BMI >30, 
and low HDL cholesterol level. They were in the order of risk factors in daytime workers 
except for high FBS and elevated TG. 
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5.2 Recommendations 
5.2.1 General Recommendation 
1- A national prevention programs need to be implemented to combat hypertension, 
diabetes, obesity, dyslipidemia, and related co morbidity and change in lifestyle, 
especially with respect to physical activity and nutrition. 
2- The MoH need to develop strategies for screening and early identification of the 
components of the MetS for all employees  
3- As blood pressure was the main risk factor of MetS, conducting regular check-up of 
BP health settings is very important.  
4- As age was one of the main determinant of MetS, MoH need to develop policies to 
regulate the work schedule of employees, particularly of those who are over 40 . 
5.2.2 Recommendation for New Areas of Research 
1- Future prospective longitudinal studies should be carried out for identifying the 
prevalence and the effect of shift work on biomarkers of MetS and inflammation on a 
large sample to include all healthcare workers in all governmental and private 
hospitals in the Gaza Strip. 
2- Considering the role of environmental interaction, job and behavioral stress, and sleep 
quality in the association between shift work and metabolic disturbances among 
healthcare workers. 
3- There is a need to conduct other quantitative studies that could study the temporal 
sequence of developing MetS 
4- It is recommended to conduct other studies that involve selection of comparative 
groups from places other than the hospitals.  
5- There is an urgent need to conduct further studies to assess the prevalence of MetS 
among different professions, separately  
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 )cibarA( mroF tnesnoC :4 xennA
 
 جبٍؼخ اىقذط                                                                                             
 ميٞخ اىصحخ اىؼبٍخ
 
 أخٍ/أختٍ اٌّشبسن/ح:
 
 أثى دَظ, ألىَ ثاعذاد ثحج ثعٕىاْ –ادسط ثىٍُخ اٌظحخ اٌعبِخ ربِعخ اٌمذط  –أٔب اٌجبحخخ: هجخ ِحّذ عشفبد
وبات الدورية عمى المؤشرات الحيوية لمتلازمة الأيض و الالتهابات بين العاممين في "تأثير المنا
  مدينة غزة ,"دراسة مقارنة-المجال الصحي
 عٍُ الأوثئخ. –اٌظحخ اٌعبِخ  ٍشد واٌحظىي عًٍ دسرخ اٌّبرغتُش فثبعتجبسٖ ِتطٍت ٌٍتخ
ثُٓ اٌعبٍُِٓ ثشىً دوسٌ و لاعتىشبف تأحُش  ِعشفخ ِذي أتشبس ِتلاصِخ الأَغَهذف هزا اٌجحج ثشىً أعبعٍ ئًٌ 
 ِذَٕخ غضح–إٌّبوثبد اٌذوسَخ عًٍ اٌّإششاد اٌحُىَخ ٌّتلاصِخ الأَغ و الاٌتهبثبد ثُٓ اٌعبٍُِٓ فٍ اٌّزبي اٌظحٍ 
أخظبئٍ تظىَش ؽجٍ _ أخظبئٍ –تّشَغ  -(أؽجبء لإرشاء هزا اٌجحج تُ اختُبس اٌعبٍُِٓ فٍ اٌّزبي اٌظحٍ ِٓ
 01( بٔخحج َتطٍت ِٓ وً شخض تعجئخ اعتجفٍ ِغتشفً اٌشفبء و ِغتشفً إٌظش فٍ ِذَٕخ غضح اٌج تحبًٌُ ؽجُخ)
 دلبئك) و عحت عُٕخ دَ لإرشاء  اٌفحىطبد اٌتبٌُخ
 لُبط ٔغجخ اٌغىش 
) , اٌذهىْ ِٕخفؼخ LDH, اٌذهىْ عبٌُخ اٌىخبفخ ( اٌىىٌُغتشويلُبط ٔغجخ اٌذهىْ ثأٔىاعهب (اٌذهىْ اٌخلاحُخ ,  
 )LDLخ (اٌىخبف
 CBCلُبط تحًٍُ اٌذَ اٌىبًِ  
 )PRC( هبثبد تلُبط ِإشش الاٌ 
 لُبط ػغؾ اٌذَ 
 لُبط اٌطىي 
 لُبط اٌىصْ 
, ورىد عًٍ الألً PECNIII-PTA-اٌىؽٓ اٌىىٌُغتشويو عُتُ تشخُض اٌّتلاصِخ الأَؼُخ عًٍ حغت ثشٔبِذ تعٍُُ 
 حلاحخ ِٓ الاتٍ:
 اٌغّٕخ اٌّتىعطخ 
 استفبع ٔغجخ اٌذهىْ اٌخلاحُخ 
 )LDHأخفبع ِغتىي اٌذهىْ اٌحُّذح ( 
 استفبع ػغؾ اٌذَ 
 استفبع اٌزٍىىص 
الإربثخ  ثاِىبٔه سفغ,  وتمذَُ اٌعُٕبد بٔخخ َفؼً الاٌتضاَ ثاربثخ الاعتجحبي ِىافمته عًٍ اٌّشبسو ٍِشبسوته تطىعُخ, ف
حمخ وعشَخ وعتغتخذَ فمؾ ٌغشع و أسغت أْ أؤوذ ٌه أْ اٌّعٍىِبد اٌتٍ تزوشهب عتىىْ ِظذس  بٔخعٓ أٌ عإاي فٍ الاعتج
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اٌجحج اٌعٍٍّ وثذوْ روش الأعّبء فبٌٕتبئذ ٌٓ تٕشش ثشىً خبص و أّب عىف تٕشش ثشىً رّبعٍ وٌٓ َٕغت أٌ شٍء اٌُه 
 ولذ تُ حظىي اٌجحج عًٍ ِىافمخ ٌزٕخ هٍغٕىٍ ولذ تُ اسفبق اٌّىافمخ.
ُٕخ ِٓ أرً اٌىطىي اًٌ دسرخ وبفُخ ِٓ اٌغلاِخ ٔتبئذ اٌجحج عىف تغبهُ فٍ وػع اٌتىطُبد اٌلاصِخ ٌٍىصاساد اٌّع
 .ٌٍعبٍُِٓ فٍ اٌّزبي اٌظحٍ
 
 
 
 
 ٗشنشا ىل ػيٚ حغِ رؼبّٗل
 
 
 اىجبحضخ / ٕجخ ػشفبد
 
 
 
 ر٘قٞغ اىَشبسك :                                                                                                     
 
 ..............................                                                                                                       
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 eriannoitseuQ gnitartsinimda fleS cibarA :5 xennA
 
 بّخ٘رط اعزجَّ
 
 أخزٜ اىنشَٝخ/ أخٜ اىنشٌٝ
فٜ َبجغزٞش ٗ رىل اعزنَبلا ىَزطيجبد اىحص٘ه ػيٚ دسجخ اى أسج٘ ٍغبػذرْب فٜ إرَبً ٕزٓ اىذساعخ
 (فشع غضٓ) ث٘ دٝظأ–جبٍؼخ اىقذط ٍِ  اىصحخ اىؼبٍخ
الأٝط ٗ الاىزٖبثبد. حٞش إُ  حذٗس ٍزلاصٍخػيٚ  ىذٗسٝخص ثذساعخ رأصٞش اىَْبٗثبد اٗ اىزٜ رخز
ٗ ػلاقزٖب مؼبٍو لاصٍخ اىَز حذٗس اىذساعخ ر٘جٞٔ الإزَبً إىٚ ٍذٙ رأصٞش اىَْبٗثبد ػيٚ ٕزٓ ٕذف
جبثخ ػيٚ ٕزٓ ٍشاض اىقيت ٗ الاىزٖبثبد ٗ رىل ٍِ خلاه الإأٗ  َٛشض اىغنشث خط٘سح ىلإصبثخ
 :اىطجٞخ راد اىؼلاقخ ثبىَزلاصٍخٗ رجشػل ثؼْٞخ دً لإجشاء ثؼط اىفح٘صبد  لاعزجبّخا
 
 
 ...........................................:صلاصٜ الاعٌ            .........................  اىشقٌ: ..............
 .......ٞخ: ...........................اىحبىخ الاجزَبػ                  ............اىجْظ: ....................
 ..........غجٞؼخ اىؼَو (اىَْٖخ): .............................   ..............   اىؼَش: ......................
 سقٌ اىج٘اه:..........................
 ....................ٍنبُ اىغنِ: ...........................................................................
 
 ٍخٌٞ                         قشٝخ                                                     ٍذْٝخ 
 
 
 :اىشٖشٛ(ثبىشٞنو ) ٍب ٕ٘ ٍغز٘ٙ دخو الأعشح
 0002 ٍِ أمضش0002                               -0001ٍِ                             0001أقو ٍِ
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 اىزبسٝخ اىَشظٜ ىيفشد ٗ اىؼبئيخ: 
 
 ٕو رؼبّٜ ٍِ ٍشض اىغنش؟
 ٔعُ o
 لا o
 جبثخ ثْؼٌإرا مبّذ الإ -
 ظٖش اىَشض؟ٍزٚ 
 ء إٌّبوثبدلجً اٌجذء فٍ أدا o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
 أخ٘ح) ٍصبة ثَشض اىغنش؟ -ٕو ىذٝل أحذ ٍِ أفشاد ػبئيزل (اى٘اىذِٝ 
 ٔعُ o
 لا o
 ٕو رؼبّٜ ٍِ ٍشض فٜ اىقيت؟
 ٔعُ o
 لا o
 ثْؼٌ ثخجبإرا مبّذ الإ -
 ظٖش اىَشض؟ ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
 أخ٘ح) ٍصبة ثأٍشاض فٜ اىقيت؟ -ػبئيزل (اى٘اىذِٝ ٕو ىذٝل أحذ ٍِ أفشاد
 ٔعُ o
 لا o
 ؟اىن٘ىٞغزشٗهٕو رؼبّٜ ٍِ اسرفبع فٜ ّغجخ 
 ٔعُ o
 لا o
 جبثخ ثْؼٌإرا مبّذ الإ -
 ؟اىن٘ىٞغزشٗهاسرفبع ّغجخ لاحظذ  ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
 ؟اىن٘ىٞغزشٗهح) ٝؼبّٜ ٍِ اسرفبع فٜ ّغجخ أخ٘ -ِٕو ىذٝل أحذ ٍِ أفشاد ػبئيزل (اى٘اىذٝ
 ٔعُ o
 لا o
 ٕو رؼبّٜ ٍِ اسرفبع فٜ ّغجخ اىذُٕ٘ اىضلاصٞخ؟
 ٔعُ o
 لا o
 جبثخ ثْؼٌإرا مبّذ الإ -
 ؟اسرفبع ّغجخ اىذُٕ٘ اىضلاصٞخلاحظذ  ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
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 أخ٘ح) ٝؼبّٜ ٍِ اسرفبع فٜ ّغجخ اىذُٕ٘ اىضلاصٞخ؟ -ٕو ىذٝل أحذ ٍِ أفشاد ػبئيزل (اى٘اىذِٝ
 ٔعُ o
 لا o
 ٕو رؼبّٜ ٍِ اسرفبع ظغػ اىذً؟
 ٔعُ o
 لا o
 جبثخ ثْؼٌإرا مبّذ الإ -
 ؟اسرفبع ظغػ اىذًلاحظذ  ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
 ظغػ اىذً؟أخ٘ح) ٝؼبّٜ ٍِ اسرفبع  -ٕو ىذٝل أحذ ٍِ أفشاد ػبئيزل (اى٘اىذِٝ
 ٔعُ o
 لا o
 ٕو رؼبّٜ ٍِ أٛ اىزٖبثبد فٜ اىجغٌ؟
 ٔعُ o
 لا o
 جبثخ ثْؼٌإرا مبّذ الإ -
 ؟ٕزٓ الاىزٖبثبد ظٖشد ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
 ٕو ىذٝل أٛ ٍشبمو صحٞخ أخشٙ؟
 ٔعُ o
 لا o
 .................................. جبثخ ثْؼٌ، ٍِ فعيل ارمشٕبإرا مبّذ الإ
 
 
 :َّػ اىحٞبح ىيفشد 
 
 ٕو أّذ ٍذخِ؟
 ِذخٓ حبٌُب o
 ِذخٓ عبثك o
 غُش ِذخٓ o
 ٕو لاحظذ صٝبدح فٜ ٗصّل فٜ اىفزشح الأخٞشح ؟
 ٔعُ o
 لا o
 إرا مبّذ الإجبثخ ثْؼٌ -
 ؟ حصيذ ٕزٓ اىضٝبدح ٍزٚ
 لجً اٌجذء فٍ أداء إٌّبوثبد o
 ثعذ اٌجذء فٍ أداء إٌّبوثبد o
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 عبػبد) أٍبً اىزيفبص/ اىحبع٘ة أصْبء ٍْبٗثزل ؟ 4ٕو رجيظ غ٘ٝلا (أمضش ٍِ 
 دائّب o
 أحُبٔب o
 ٔبدسا o
 لا أرٍظ أِبَ اٌتٍفبص/اٌحبعىة o
 ٕو رَبسط اىشٝبظخ ٗ خص٘صب سٝبظخ اىَشٜ؟
 دائّب o
 أحُبٔب o
 ٔبدسا o
 لا أِبسعهب o
 إرا مْذ رَبسط أٛ ّ٘ع ٍِ أّ٘اع اىشٝبظخ الأخشٙ ، ٍِ فعيل حذدٕب ............................ -
 
 :خ ػَو اىفشدغجٞؼ 
 ٕو عجق ٗ أُ ميفذ ثأداء ٍْبٗثبد ىٞيٞخ فٜ اىؼَو؟
 دائّب o
 أحُبٔب o
 غُش ِىٍف o
 ٕو أّذ ٍنيف ثأداء ٍْبٗثبد ىٞيٞخ فٜ اىؼَو حبىٞب ؟
 دائّب o
 أحُبٔب o
 غُش ِىٍف o
 مٞف ٝنُ٘ ػَيل خلاه الأعج٘ع؟
 فتشح طجبحُخ فمؾ o
 فتشح طجبحُخ و ِغبئُخ فمؾ o
 فتشح طجبحُخ و ِغبئُخ وٌٍُُخ o
 ِغبئُخ و ٌٍُُخ فمؾ فتشح o
 فتشح ِغبئُخ فمؾ o
 فتشح ٌٍُُخ فمؾ o
 أٍعٞذ/ رَعٜ ٍؼظٌ اىَْبٗثخ فٞٔ ؟ زٍٛب ٕ٘ اىَنبُ اى
 لغُ الأؽفبي o
 لغُ اٌحؼبٔخ o
 لغُ اٌمٍت و الأوعُخ اٌذِىَخ o
 اٌعٕبَخ اٌّشوضح o
 لغُ الاعتمجبي و اٌطىاسب o
 ألغبَ اٌجبؽٕخ o
 ألغبَ اٌزشاحخ o
 لغُ إٌغبء و اٌىلادح o
 ٍه حذدهب ..........................................غُش رٌه, ِٓ فؼ o
 001
 
 ؟ىٞيٞخ مٌ ػذد اىغْ٘اد اىزٜ ميفذ فٖٞب ثأداء ٍْبٗثبد
 ٌُ أوٍف o
 عٕخ o
 عٕتبْ o
 حلاث عٕىاد o
 أسثعخ عٕىاد o
 خّظ عٕىاد o
 أوخش ِٓ رٌه ,ِٓ فؼٍه حذدهب .................................... o
 ٖشٝب؟مٌ ػذد اىَْبٗثبد اىزٜ رقً٘ ثأدائٖب ش  
 غُش ِىٍف o
 )2-1( o
 )4-3( o
 )6-5( o
 )8-7( o
 )01-9( o
 أوخش ِٓ رٌه , ِٓ فؼٍه حذدهب ..................... o
 
 
 
 أّب ٍ٘افق/ٍ٘افقخ ػيٚ رؼجئخ ٕزٓ الاعزجبّخ اىزٜ رزؼيق ثصحزٜ           اىز٘قٞغ:....................
 
 شنشا ىنٌ ػيٚ حغِ رؼبّٗنٌ اىجبحضخ/ ٕجخ ٍحَذ ػشفبد
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The clinical tests  دبص٘حفىا(خٞنْٞٞيملإا) 
 
The laboratory tests)خٝشجخَىا دبص٘حفىا( 
Any further tests/comments: 
 
 
 
 
 
Value  The test 
…….cm  Length  
………kg  Weight  
………. Body Mass Index (BMI) 
……….mm Hg Blood pressure 
Normal Range Results Test Name 
  Normal      70-99mg/dl    
Prediabetes  100-125mg/dl 
Diabetes    ≥ 126mg/dl 
 Fasting blood sugar 
(FBS) 
Normal <200 mg/dl 
Borderline High 200-239 mg/dl 
High >240 mg/dl 
 T. Cholesterol  
Desirable <200 mg/dl 
Borderline High 200-400 mg/dl 
Elevated >400 mg/dl 
 Triglyceride (TG) 
40-80 mg/dl  HDL-High density lipoprotein 
Desirable <130 mg/dl 
Borderline High risk 130-160mg/dl 
High risk >160 mg/dl 
 
 LDL-low density lipoprotein 
Up to 5.0 mg/L  CRP C- Reactive Protein 
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Annex 6: Helsinki Committee Approval Letter 
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Annex 7: Al- Quds University Permission 
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Annex 8: Ministry of health Permission Letter 
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Annex 9: List of Expert Names 
 
 Dr. Yehia Abed                        Associate professor of epidemiology 
 Dr.   Bassam Abu Hamad 
Prof. Mohammed Shubair 
Prof. Mahmoud Sirdah 
Prof. Yousef El- Jeesh  
Prof.  Abdelraouf Elmanama 
Dr. Basem Ayesh    
Dr. Mohammed Hamdan           
 Dr. Abeer Al- Qutati                  
 Dr. Nabeel El- Eaila           
Dr. Ahmed Nijim                      
Dr. Saleh Mwafi                        
 
  Associate professor of human resource management 
Professor of laboratory medicine 
Professor of blood pathophysiology and molecular genetics 
Professor of public health 
Professor of microbiology 
Associate professor of medical and molecular genetics 
Assistant professor of microbiology 
Assistant professor of clinical chemistry 
Assistant professor of medical and molecular microbiology 
Assistant professor of nursing 
Assistant professor of physiology 
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Annex 10: Sample size of Self-administering questionnaire 
 ASH ANPH 
 Number of 
healthcare 
workers 
Sample size 
Number of 
healthcare 
workers 
Sample size 
Physicians 470 97 55 12 
Nurses 680 140 120 25 
Others(medical 
technologists, 
radiologists, and 
radiologic 
technologists) 
118 24 31 6 
Grand Total 1268 262 206 43 
Source: ASH and ANPH reports  
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Annex 11: AL-Shifa Hospital 
Al-Shifa Hospital (ASH) is the biggest governmental health organization in the Gaza Strip. 
It is considered as a secondary health care delivery organization. The hospital has been 
established in 1946 on an area of over 45,000 sq. M. ASH is subdivided into three 
hospitals as surgical hospital, medical hospital and obstetrics and gynecology hospital. 
In 2006, the hospital capacity grows to be 590 hospitalization beds, there were 93 daily 
care beds in the hospital; also, a total number of employees are 1285 represents all 
categories work in the hospital (Aljeesh & Alkariri, 2010). The hospital offers paramedical 
services such as laboratory, radiography, pharmacy and physiotherapy, each hospital has 
its own management team and manager submit to the general director of the hospital. The 
average occupancy rate at ASH in 2002 was 84,6%, including the occupancy rate of daily 
care beds, the average length of stay was 3 days (MOH, 2005). 
Outpatients is the biggest department in ASH. It includes twenty one sub-clinics related to 
the medical, surgical and paramedical services like, x-ray department, laboratory minor 
operations room and admission department. The sub-clinics were distributed over the five 
days. Its services about 90,00 patients every year (ASH records, 2009). 
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Annex 12: Al- Nassir Pediatric Hospital 
Al- Nassir Pediatric Hospital deals only with children aged 12 years or less. It is located in 
Gaza and it had been constructed in 1962 for gynecological and obstetric cases but it was 
changed in 1972 to pediatric hospital. 
The hospital developed very much especially after the arrival of Palestinian National 
Authority in 1994, so as to meet philosophy which is based on delivery of high standard 
health care to Palestinian children with in the available resources. As we see, the number 
of beds has increased in addition to improvement of qualification and abilities of the staff 
in quality and quantity. 
Also, subspecialty departments like hematology and oncology department were created to 
offer treatment for blood diseases and cancer which ultimately lead to substantial decrease 
in referral of patients to abroad. Intensive care unit and nephrology department deal with 
the peritoneal dialysis for patients with renal failure.  
Great development in both quality and quantity was also observed in laboratory and X-ray 
departments. A big advance occurred in nursing power as the number of nurses was 
doubled in addition to achievement in qualification and training and a significant number 
of nurses have got a master degree in nursing, administration and mental health. 
Finally it was a big achievement when ANPH has been recognized as teaching hospital by 
Egypt, faculty of medicine and paramedical colleges. The fiscal consequences of political 
developments in Palestine in 2006 have had an impact on the Ministry of Health‘s budget, 
and consequently on the delivery of health services and programmes. For instance, they 
affected its capacity to maintain a stock of pharmaceuticals and consumables and pay 
salaries to its staff, which has resulted in a prolonged health workers‘ strike across the 
West Bank (Mushtaha, 2009). 
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 cibarA ni tcartsbA
 لحيوية لمتلازمة الأيض و الالتهابات بين العاممين تأثير المناوبات الدورية عمى المؤشرات ا
 مدينة غزة-في المجال الصحي
 إعداد: هبة محمد عرفات
 إشراف: د. ناهض المحام
 ممخص الدراسة
صابة بمتلازمة الأيض الغذائي وىي متلازمة معقدة تؤدي الإ المناوبات الدورية في العمت  تساىث في  زيادة خطرإج 
أجريت ىذه الدراسة لمعرفة  .و  مرض السكري مج النوع الثانيأمراض القمب والأوعية الدموية و / أإلى زيادة الإصابة ب
مدى انتشار" متلازمة الأيض"  بيج العامميج في المجات  الصحي, ودراسة تأثير المناوبات الدورية عمى عوامت الخطر 
 بحيث " مج العامميج في المجات الصحي,013" لمتلازمة الأيض و الالتيابات. أجريت دراسة مقطعية عمى عينة مج 
حيث  مج الأشخاص الذيج يأخذوج مناوبات دورية؛ 012شخص يعمموج صباحًا في الوقت الحالي مع  001مقارنة  تث
 ,الوظيفة ,الدخت الاجتماعية ,الحالة ,العمر الجنس( الديموغرافيا الاجتماعيةتوزيع استبانة تشمت معمومات عج  تث
والفحص  العمت حوت الميني التاريخ, )البدني والنشاط التدخيج(الصحية  السموكيات, الطبي ,التاريخ) والمحافظة
 المخبرية. الفحوصاتو  ضغط الدث الشرياني ات الأنثروبومترية و قياساسقيالالصحي بما في ذلة 
اء المتلازمة إذا كاج الفررد وتحديد متلازمة الأيض. تث استيف " لتشخيص,")III( PTA PECNولقد تث استخداث بروتوكوت
فرري النسرراء؛ نسرربة السرركر  >mc88و فرري الرجررات, >201mc: محرريط الخصررر الآتيررةلديررو ثلاثررة أو أكثررر مررج المعررايير 
الكولسرتروت , ≥ ld/gm 051الردىوج الثلاثيرة فري الردث ,≥ 031/58gHmm  , ضرغط الردث ld/gm 011<صرائث
 SSPSاث. ترث إجرراء التحميرت الإحصرائي باسرتخداث ب نرام  فري الإنر> 05ld/gmفري الرذكور و > 04ld/gmالحميرد 
٪ 0.9٪ (4.8 كانرت بريج العرامميج فري المجرات الصرحي تلازمرة الأيرضانتشرار م أظيررت النترائ  أج نسربة .02إصردار 
دوج فرررب برريج الررذكور والإنرراث و طبيعررة  (٪ برريج العررامميج الررذيج يأخررذوج مناوبررات دو يررة1.8برريج العررامميج صررباحا و 
 PRC ارتفراع نسربة وكراج العامرت الأكثرر تغيررا فري كثيرر مرج الأحيراج بريج العرامميج فري المجرات الصرحي ىرو المناوبرات.
, و استفابع ِإشاش )%8.42( الكوليسرتروت, استفابع ِغاتىي  )%5.53(٪), يمييرا ارتفراع مسرتوى الردىوج الثلاثيرة5.44(
وكانرت عوامرت الخطرر الرئيسرية لمتلازمرة الأيرض بريج العرامميج فري المناوبرات  %).6.02(  03> IMB(وتٍاخ اٌزغاُ (
 ارتفراع , )8.512 -4.61 ,IC %59 ;5.95=RO( الردث كالاتي ارتفاع ضرغطمرتبة تنازليا  في كلا الجنسيج الدورية
 %59;3.24=RO( ثلاثيةال ارتفاع نسبة الدىوج ),1.941 -9.21 ,IC %59;9.34=RO( الدث في السكر مستوى 
 وانخفراض ,)6.43 -4 ,IC %59 ;8.11=RO() 03> الجسرث كتمرة مؤشرر ارتفراع( ,السرمنة )6.623 -5.5 ,IC
 تنتشرر متلازمرة الأيرض مج خلات النترائ  تبريج أج ).1.6 -3.0 ,IC %59 ;6.1 = RO( الحميد الكولستروت مستوى
دة مطرردة فري معردت انتشرارىا مرع ازديراد العمرر ومؤشرر كتمرة مرع زيرا بريج العرامميج فري المجرات الصرحي فري قطراع غرزة ؛
 أخررى عوامرتقد  كود ه اكد    ,الجسث, وليس ىناة علاقة مباشرة بيج  المناوبات الدو يرة و متلازمرة الأيرض  والالتيابرات
الدو يرة. و كرذلة المتلازمرة مرج المناوبرات  أكبر عمى حدوث نفسيا ليا تأثير والوظيفة الحياة, نمط الوراثية, العوامت مثت
والحررث عمررى عرردث إغفررات  اضررطرابات ارتفرراع ضررغط الرردث برريج العررامميج فرري المجررات الصررحي, عررلاجنحررج بحاجررة إلررى 
نحررج بحاجررة إلررى اىتمرراث وزارة الصررحة جنبررا إلررى جنررب مررع الممارسررة  الظررروا الصررحية لمرروظفي المستشررفيات و أيضررا
حررردوث أمرررراض القمررب والأوعيرررة الدمويرررة عنرررد  إمكانيررةقايرررة مرررج الفرديررة لمسرررموكيات الصرررحية لإدارة متلازمررة الأيرررض لمو 
 العامميج في المجات الصحي.
 .المناوبات الدورية, الالتيابات, وعوامت الخطرالعامميج في , العامميج صباحا, متلازمة الأيض الكممات المفتاحية:
